HOXA2-related bilateral microtia is a developmental ear-malformation spectrum with autosomal recessive and dominant presentations. A homozygous homeodomain p.Gln186Lys allele in an Iranian family is associated with grade II bilateral microtia, severe to profound mixed hearing impairment and partial cleft palate. Heterozygous truncating alleles cause dominant bilateral microtia with variable hearing impairment; mixed loss is documented in a dominant family, whereas examined members of another family had normal hearing. These allelic presentations are retained as separate subtypes of the same entry. HOXA2 assigns second-pharyngeal-arch identity and supports auricular and middle-ear development. Mouse null and conditional experiments establish dose- and timing-sensitive developmental functions, but do not demonstrate that human ossicular malformations reproduce the complete homeotic transformation of a mouse null. Most of the auricle is linked to second-arch mesenchyme; descriptions that include the tragus and auricular root require first-arch contributions to be considered. Haploinsufficiency is an inferred mechanism for dominant truncating alleles, with impaired HMX1 enhancer activation shown in reporter assays for p.Lys213* and p.Gln235*. Residual function of p.Gln186Lys and the relative contributions of tongue mechanics and intrinsic palatal fusion to the human cleft remain unresolved.
Ask a research question about Bilateral Microtia-Deafness-Cleft Palate Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
Conditions with similar clinical presentations that must be differentiated from Bilateral Microtia-Deafness-Cleft Palate Syndrome:
name: Bilateral Microtia-Deafness-Cleft Palate Syndrome
creation_date: "2026-09-03T00:00:00Z"
category: Mendelian
description: >-
HOXA2-related bilateral microtia is a developmental ear-malformation spectrum with autosomal recessive and
dominant presentations. A homozygous homeodomain p.Gln186Lys allele in an Iranian family is associated with
grade II bilateral microtia, severe to profound mixed hearing impairment and partial cleft palate. Heterozygous
truncating alleles cause dominant bilateral microtia with variable hearing impairment; mixed loss is documented
in a dominant family, whereas examined members of another family had normal hearing. These allelic presentations
are retained as separate subtypes of the same entry.
HOXA2 assigns second-pharyngeal-arch identity and supports auricular and middle-ear development. Mouse null
and conditional experiments establish dose- and timing-sensitive developmental functions, but do not demonstrate
that human ossicular malformations reproduce the complete homeotic transformation of a mouse null. Most of
the auricle is linked to second-arch mesenchyme; descriptions that include the tragus and auricular root
require first-arch contributions to be considered. Haploinsufficiency is an inferred mechanism for dominant
truncating alleles, with impaired HMX1 enhancer activation shown in reporter assays for p.Lys213* and p.Gln235*.
Residual function of p.Gln186Lys and the relative contributions of tongue mechanics and intrinsic palatal
fusion to the human cleft remain unresolved.
disease_term:
preferred_term: bilateral microtia-deafness-cleft palate syndrome
term:
id: MONDO:0012854
label: bilateral microtia-deafness-cleft palate syndrome
parents:
- congenital malformation of the ear
- neurocristopathy
- hereditary disease
synonyms:
- microtia, hearing impairment, and cleft palate
- microtia with or without hearing impairment
- HOXA2-related microtia
- MHIC
references:
- reference: PMID:18394579
title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
- reference: PMID:23775976
title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
- reference: PMID:27503514
title: Identification of a second HOXA2 nonsense mutation in a family with autosomal dominant non-syndromic microtia and distinctive ear morphology.
- reference: PMID:32649979
title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
- reference: DOI:10.3389/fsurg.2022.944223
title: Integrated microtia and aural atresia management
- reference: PMID:10529419
title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
- reference: PMID:11578867
title: Different levels of Hoxa2 are required for particular developmental processes.
- reference: PMID:19653318
title: Hoxa2 plays a direct role in murine palate development.
- reference: PMID:24067355
title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
- reference: PMID:7903600
title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
- reference: PMID:7903601
title: A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene.
- reference: url:https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
title: https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
- reference: url:https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
title: https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/4143470/
title: 'The genetics of auricular development and malformation: new findings in model systems driving future directions for microtia research - PMC'
has_subtypes:
- name: AR-MHIC
display_name: Autosomal recessive microtia, hearing impairment and cleft palate (HOXA2 p.Q186K)
description: >-
The original consanguineous Iranian family has homozygous p.Gln186Lys with bilateral microtia, prelingual
severe to profound mixed hearing impairment and partial cleft palate. Three examined relatives had marked
canal stenosis and ossicular abnormalities; one had unilateral inner-ear agenesis. These observations do
not establish universal features of all biallelic HOXA2 variants.
genes:
- preferred_term: HOXA2
term:
id: hgnc:5103
label: HOXA2
evidence:
- reference: PMID:18394579
reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
explanation: >-
Defines the recessive subtype's three-component phenotype in the family
the disease concept is named for.
- name: AD-Microtia
display_name: Autosomal dominant nonsyndromic bilateral microtia (HOXA2 haploinsufficiency)
description: >-
Heterozygous truncating HOXA2 variants segregate with dominant bilateral microtia. Hearing varies among
families: the p.Gln235* family studied by Brown and colleagues includes mild to severe mixed loss, whereas
the examined p.Glu224* family members had normal hearing. The characterized dominant families do not show
the cleft-palate presentation of the original recessive family. Haploinsufficiency is proposed; transcript
decay and an exact reduction in patient protein abundance were not measured in these reports.
genes:
- preferred_term: HOXA2
term:
id: hgnc:5103
label: HOXA2
evidence:
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Our data extend these conclusions and define HOXA2 haploinsufficiency as the first genetic cause for autosomal-dominant nonsyndromic microtia."
explanation: Establishes the dominant, haploinsufficiency-driven subtype.
- reference: PMID:27503514
reference_title: Identification of a second HOXA2 nonsense mutation in a family with autosomal dominant non-syndromic microtia and distinctive ear morphology.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Here we describe a five-generation family with isolated bilateral microtia segregating as an autosomal dominant trait."
explanation: >-
A second, independent dominant family in which the microtia is isolated.
inheritance:
- name: Autosomal recessive
description: >-
Homozygosity for the HOXA2 homeodomain missense p.Q186K in a consanguineous
Iranian family, mapped by genome-wide linkage to 7p14.3-p15.3.
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
evidence:
- reference: PMID:18394579
reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
explanation: >-
Recessive segregation in a consanguineous pedigree establishes the
biallelic mode for this subtype.
- name: Autosomal dominant
description: >-
Heterozygous truncating HOXA2 variants segregate with bilateral microtia in multigeneration pedigrees.
Hearing impairment is variable, so auricular morphology and audiology both contribute to family assessment.
inheritance_term:
preferred_term: Autosomal dominant inheritance
term:
id: HP:0000006
label: Autosomal dominant inheritance
evidence:
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The HOXA2 variant was segregated with microtia and hearing loss in the family and was not seen in 6,500 individuals sequenced by the NHLBI Exome Sequencing Project or in 218 control individuals sequenced in this study."
explanation: >-
Co-segregation with the trait plus absence from large control sets
supports the dominant allele's causality.
- reference: PMID:27503514
reference_title: Identification of a second HOXA2 nonsense mutation in a family with autosomal dominant non-syndromic microtia and distinctive ear morphology.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "In our family, sequence analysis detected a heterozygous protein truncating nonsense variant"
explanation: >-
Full segregation of a second heterozygous truncating allele in an
independent family.
pathophysiology:
- name: HOXA2 Loss of Function
biological_scale: MOLECULAR
description: >-
Disease-associated alleles include heterozygous truncating variants p.Lys213*, p.Glu224* and p.Gln235*,
and the recessive homeodomain missense p.Gln186Lys. Dominant haploinsufficiency is inferred from segregation
and variant class, with impaired enhancer activation measured for two truncating alleles. The p.Gln186Lys
DNA-binding effect is a homology-model prediction; the founding study did not measure residual protein
activity or show functional complementation.
genes:
- preferred_term: HOXA2
term:
id: hgnc:5103
label: HOXA2
molecular_functions:
- preferred_term: DNA-binding transcription factor activity
modifier: LOSS_OF_FUNCTION
term:
id: GO:0003700
label: DNA-binding transcription factor activity
biological_processes:
- preferred_term: anterior/posterior pattern specification
modifier: ABNORMAL
term:
id: GO:0009952
label: anterior/posterior pattern specification
evidence:
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Exome sequencing of affected family members detected only seven shared, rare, heterozygous, nonsynonymous variants, including one protein truncating variant, a HOXA2 nonsense change (c.703C>T, p.Q235*)."
explanation: Identifies the truncating allele class underlying the dominant form.
- reference: PMID:18394579
reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Subsequent DNA sequence analysis of the HOXA1 and HOXA2 homeobox genes from the candidate region identified an interesting HOXA2 homeodomain variant: a change in a highly conserved amino acid (p.Q186K)."
explanation: Identifies the recessive homeodomain missense allele.
- reference: PMID:18394579
reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
supports: SUPPORT
evidence_source: COMPUTATIONAL
directness: INDIRECT
snippet: "In the model of the mutant homeodomain, the position of the mutant lysine side chain is consistently farther away from a nearby phosphate group; this altered position results in the loss of a hydrogen bond and affects the DNA-binding activity."
explanation: >-
The DNA-binding consequence of p.Q186K is a homology-modelling prediction,
not a measurement; recorded as computational and indirect.
downstream:
- target: Impaired Transactivation of the Long-Range HMX1 Enhancer
description: >-
The p.Lys213* and p.Gln235* variants impair activation of the long-range HMX1 enhancer in a dual-luciferase
assay; the abstract does not establish complete abolition of activity.
causal_link_type: DIRECT
evidence:
- reference: PMID:32649979
reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Using dual luciferase reporter assays, we showed that both HOXA2 mutations have impaired activation of the long-range enhancer of HMX1."
explanation: >-
The reporter assay directly measures impaired enhancer activation by these two variants, rather than
proving complete absence of activity in patients.
- target: Loss of Second Pharyngeal Arch Neural Crest Identity
description: >-
HOXA2 is the selector gene that assigns second-arch identity to the
cranial neural crest cells populating that arch; without it they adopt
first-arch identity.
causal_link_type: DIRECT
evidence:
- reference: PMID:7903601
reference_title: "A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "The ground pattern program appears to be modified in the mouse first arch by a Hox-independent process, whereas Hoxa-2 acts as a selector gene in the second arch."
explanation: >-
Establishes HOXA2's selector-gene role in the second arch, the step this
edge represents.
- target: Intrinsic Palatal Shelf Fusion Defect
description: >-
A route that does not run through the pharyngeal arches at all. Hoxa2 is
expressed in the palate itself, and knocking it down there reduces the
rate at which the shelves fuse. The intermediates the authors name -
increased cell proliferation, and de-repression of the Hoxa2 targets
Msx1, Bmp4, Barx1 and Ptx1 - are candidates they identify but do not
trace to the fusion failure.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:19653318
reference_title: Hoxa2 plays a direct role in murine palate development.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Knocking down Hoxa2 expression with antisense retroviral constructs resulted in decreased fusion rates than corresponding controls."
explanation: >-
Loss of Hoxa2 in the palate reduces shelf fusion, the step this edge
represents; the experiment is a knockdown in palate culture.
directness: INDIRECT
- reference: PMID:19653318
reference_title: Hoxa2 plays a direct role in murine palate development.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Hoxa2 also repressed the expression of its downstream targets Msx1, Bmp4, Barx1, and Ptx1 within the palate."
explanation: >-
Altered target-gene expression provides candidates, but the study does not trace a complete causal
chain from any one target to failed fusion.
directness: INDIRECT
- target: External Auditory Canal Stenosis
description: >-
The HOXA2 genotype segregates with canal narrowing in the recessive family; the specific developmental
intermediates remain unresolved.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
The results of high-resolution CT scanning confirmed that the external auditory canal was severely
narrowed bilaterally in the cartilaginous part of the auditory canal and almost atretic in part of
the bony portion in all patients.
explanation: >-
CT in the three examined recessive-family members, not every person with HOXA2-related disease.
- target: Unilateral Inner-Ear Aplasia
description: >-
The inner-ear malformation co-occurs with homozygous p.Gln186Lys in one relative. Its developmental relation
to HOXA2 remains uncertain and should not be attributed to ossicular homeosis.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
The inner-ear structures were normal in patients V: 2 and V: 3, but there were no inner-ear structures
on the left side for IV: 3.
explanation: >-
Unilateral inner-ear agenesis in one recessive-family member, with normal inner-ear anatomy in the
other two imaged relatives.
- target: Unilateral Facial Paresis
description: >-
Facial weakness was observed in one homozygous relative; a specific neural developmental mechanism was
not established.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
Individual number V: 2 also had a paresis on the right side of the face.
explanation: >-
Single affected relative; facial-nerve hypoplasia was suspected clinically but was not confirmed by
brain MRI.
- name: Impaired Transactivation of the Long-Range HMX1 Enhancer
biological_scale: MOLECULAR
description: >-
The p.Lys213* and p.Gln235* variants impair activation of a long-range HMX1 enhancer in dual-luciferase
assays. Prior mouse work places Hoxa2 upstream of Hmx1 in ear development. The assay links these patient
variants to a candidate effector, but does not measure the entire developmental pathway in human auricular
tissue.
genes:
- preferred_term: HOXA2
term:
id: hgnc:5103
label: HOXA2
biological_processes:
- preferred_term: ear morphogenesis
modifier: ABNORMAL
term:
id: GO:0042471
label: ear morphogenesis
evidence:
- reference: PMID:32649979
reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "In mouse, Hoxa2 can bind to a long-range enhancer and regulate expression of the Hmx1 gene, which is a crucial transcription factor in eye and ear development."
explanation: >-
Establishes the HOXA2-HMX1 enhancer relationship; demonstrated in mouse.
quote_role: BACKGROUND
- reference: PMID:32649979
reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
supports: SUPPORT
evidence_source: IN_VITRO
directness: DIRECT
snippet: >-
Using dual luciferase reporter assays, we showed that both HOXA2 mutations have impaired activation of
the long-range enhancer of HMX1.
explanation: >-
Direct reporter result for p.Lys213* and p.Gln235*; impairment is not equivalent to a proven null effect.
downstream:
- target: Failed Auricular Morphogenesis
description: >-
Reduced HMX1 activation is the candidate route from the HOXA2 alleles to
the external ear defect; the link to the human auricle phenotype is
inferred, not measured in patient tissue.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:32649979
reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "In mouse, Hoxa2 can bind to a long-range enhancer and regulate expression of the Hmx1 gene, which is a crucial transcription factor in eye and ear development."
explanation: >-
Supports HMX1 as an ear-development effector downstream of HOXA2;
the connection to the human auricle is an inference from this.
directness: INDIRECT
quote_role: BACKGROUND
- name: Loss of Second Pharyngeal Arch Neural Crest Identity
biological_scale: CELLULAR
conforms_to: "pharyngeal_arch_patterning_serial_homology#Cranial Neural Crest and Pharyngeal Arch Program Perturbation"
description: >-
Hoxa2-null mouse embryos retain rhombomeric and neural crest segmentation but lose normal second-arch mesenchymal
identity, producing first-arch-like skeletal derivatives. This supports an identity-assignment role. The
cited abstract does not separately demonstrate normal migration, cell number or survival, and the complete-null
result should not be equated with every human HOXA2 allele.
cell_types:
- preferred_term: second-arch neural crest cell
term:
id: CL:0011012
label: neural crest cell
biological_processes:
- preferred_term: neural crest cell development
modifier: ABNORMAL
term:
id: GO:0014032
label: neural crest cell development
- preferred_term: pharyngeal system development
modifier: ABNORMAL
term:
id: GO:0060037
label: pharyngeal system development
locations:
- preferred_term: second pharyngeal arch
term:
id: UBERON:0003066
label: pharyngeal arch 2
evidence:
- reference: PMID:7903601
reference_title: "A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "While rhombomeric and neural crest cell (NCC) segmentation was not affected, mesenchymal NCC derivatives of the second arch were lacking, and second arch mesenchymal NCC identity was changed to first arch identity, resulting in homeotic transformation of second to first arch skeletal elements."
explanation: >-
Direct mouse evidence for preserved segmentation with changed second-arch identity; migration and survival
were not separately established by this quotation.
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/4143470/
reference_title: 'The genetics of auricular development and malformation: new findings in model systems driving future directions for microtia research - PMC'
supports: SUPPORT
evidence_source: OTHER
directness: DIRECT
snippet: >-
By definition, the pinna encompasses all external structures of the ear, including the tragus and root.
explanation: >-
This review qualifies the terminology of the mouse lineage claim; it is not a new lineage-tracing experiment.
quote_role: REVIEW_SYNTHESIS
downstream:
- target: Homeotic Transformation of Second-Arch Skeletal Derivatives
description: >-
Mis-specified second-arch crest builds first-arch structures instead of
second-arch ones.
causal_link_type: DIRECT
evidence:
- reference: PMID:7903600
reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Histological analysis suggested that this duplication resulted from the transformation of skeletal elements derived from the second branchial arch into more anterior structures, resulting in a duplication of Meckel's cartilage adjacent to the otic capsule."
explanation: >-
Independently documents the transformation of second-arch skeletal
elements toward anterior (first-arch) structures.
- target: Failed Auricular Morphogenesis
description: >-
Hoxa2-expressing second-arch mesenchyme supplies the auricular territory examined in the mouse fate-mapping
study. Its loss disrupts that territory; the result should not be generalized to every human external-ear
structure.
causal_link_type: DIRECT
evidence:
- reference: PMID:24067355
reference_title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "By genetic fate mapping we found that the mouse auricle (or pinna) derives from the Hoxa2-expressing neural crest-derived mesenchyme of the second pharyngeal arch, and not from a composite of first and second arch mesenchyme as previously proposed based on morphological observation of human embryos."
explanation: >-
Mouse fate mapping supports a major second-arch contribution. The extent depends on how the auricle
is defined; the tragus and root require separate consideration.
- target: Mis-Attachment of the Extrinsic Tongue and Hyoid Muscles
description: >-
The same rhombencephalic neural crest that builds the craniofacial
skeleton also patterns the craniofacial muscles, and Hoxa2 mutants have
abnormal attachments and trajectories of the extrinsic tongue and hyoid
muscles. How the arch-identity lesion produces that particular
mis-routing was not worked out, so the intermediates are recorded as
unknown.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:10529419
reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "The rhombencephalic neural crest play several roles in craniofacial development. They give rise to the cranial sensory ganglia and much of the craniofacial skeleton, and are vital for patterning of the craniofacial muscles."
explanation: >-
States that craniofacial muscle patterning depends on the same neural
crest population whose identity is lost at this node.
- target: Middle-Ear Ossicular Dysplasia
description: >-
The relationship of second-arch patterning to human ossicular dysplasia is inferred from developmental
models and family anatomy; the intervening human developmental steps have not been measured.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
In all three patients the malformed ossicular chain seemed fixated by an incomplete atretic plate.
explanation: >-
CT findings in the three examined members of the recessive family; fixation was described as apparent
on imaging.
- name: Homeotic Transformation of Second-Arch Skeletal Derivatives
biological_scale: TISSUE
conforms_to: "pharyngeal_arch_patterning_serial_homology#Disrupted Pharyngeal-Arch Patterning and Neural-Crest Skeletogenesis"
description: >-
Hoxa2-null mice lose second-arch skeletal elements and develop duplicated first-arch structures, including
middle-ear ossification centers and a second Meckel cartilage beside the otic capsule. This is a model-organism
developmental phenotype. Human imaging and surgery establish ossicular dysplasia and fixation, but do not
demonstrate this complete homeotic duplication. This node has no downstream human-phenotype links because
the complete homeotic transformation is documented only in mice.
cell_types:
- preferred_term: neural crest cell
term:
id: CL:0011012
label: neural crest cell
biological_processes:
- preferred_term: embryonic cranial skeleton morphogenesis
modifier: ABNORMAL
term:
id: GO:0048701
label: embryonic cranial skeleton morphogenesis
- preferred_term: embryonic skeletal system morphogenesis
modifier: ABNORMAL
term:
id: GO:0048704
label: embryonic skeletal system morphogenesis
locations:
- preferred_term: auditory ossicle
term:
id: UBERON:0001686
label: auditory ossicle bone
evidence:
- reference: PMID:7903600
reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Analysis of stained skeletons revealed that homozygous mutant animals contained multiple cranial skeletal defects, including a duplication of the ossification centers of the bones of the middle ear."
explanation: >-
Documents the middle-ear skeletal consequence of the second-arch
transformation.
- reference: PMID:7903600
reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Skeletal elements normally derived from the second arch were absent in the mutants."
explanation: >-
Confirms loss, not merely mis-shaping, of the second-arch skeletal
derivatives.
- name: Middle-Ear Ossicular Dysplasia
description: >-
Malformed or fixed ossicles are documented directly in both recessive and dominant HOXA2 families. Recessive
cases had a malformed chain apparently fixed by an incomplete atretic plate; dominant cases included abnormal
stapes crura, absent stapedial tendon and a rigid chain. These observations support a conductive deficit
without assuming mouse-like duplication in humans.
biological_scale: TISSUE
evidence:
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
In all three patients the malformed ossicular chain seemed fixated by an incomplete atretic plate.
explanation: >-
CT findings in the three examined members of the recessive family; fixation was described as apparent
on imaging.
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
In individual II.2, the stapes was noted to have a thickened posterior crus and an absent anterior crus,
and the stapedial tendon was absent.
explanation: >-
Operative observation in one dominant-family member.
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Individual II.4 had a rigid ossicular chain.
explanation: >-
Operative observation in another member of the same dominant family.
downstream:
- target: Hearing Impairment
description: >-
Ossicular malformation and fixation impair sound transmission and can account for the conductive component.
This mechanism does not explain a sensorineural component.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
In all three patients the malformed ossicular chain seemed fixated by an incomplete atretic plate.
explanation: >-
CT findings in the three examined members of the recessive family; fixation was described as apparent
on imaging.
- target: Mixed Hearing Impairment
description: >-
Ossicular malformation and fixation impair sound transmission and can account for the conductive component.
This mechanism does not explain a sensorineural component.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
In all three patients the malformed ossicular chain seemed fixated by an incomplete atretic plate.
explanation: >-
CT findings in the three examined members of the recessive family; fixation was described as apparent
on imaging.
- target: Abnormal Middle-Ear Ossicles
description: >-
The structural abnormality is the directly observed phenotype.
causal_link_type: DIRECT
evidence:
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
In all three patients the malformed ossicular chain seemed fixated by an incomplete atretic plate.
explanation: >-
CT findings in the three examined members of the recessive family; fixation was described as apparent
on imaging.
locations:
- preferred_term: auditory ossicle bone
term:
id: UBERON:0001686
label: auditory ossicle bone
- name: Failed Auricular Morphogenesis
biological_scale: TISSUE
conforms_to: "pharyngeal_arch_patterning_serial_homology#Serially Homologous Craniofacial Malformation Across Arch Derivatives"
description: >-
The auricle fails to form normally. Timing determines severity in the mouse:
early Hoxa2 inactivation abolishes the auricle and duplicates the external
auditory canal, while late inactivation leaves a hypomorphic auricle
resembling the human phenotype. Hoxa2 acts on pinna morphogenesis partly
through BMP signalling and Eya1 expression.
biological_processes:
- preferred_term: ear morphogenesis
modifier: ABNORMAL
term:
id: GO:0042471
label: ear morphogenesis
- preferred_term: face morphogenesis
modifier: ABNORMAL
term:
id: GO:0060325
label: face morphogenesis
locations:
- preferred_term: auricle
term:
id: UBERON:0001757
label: pinna
evidence:
- reference: PMID:24067355
reference_title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "In mice, Hoxa2 inactivation at early gestational stages results in external auditory canal (EAC) duplication and absence of the auricle, whereas its late inactivation results in a hypomorphic auricle, mimicking the human HOXA2 mutant condition."
explanation: >-
Establishes both the auricular defect and its dependence on the timing of
Hoxa2 loss.
- reference: PMID:24067355
reference_title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Hoxa2 partly controls the morphogenesis of the pinna through the BMP signalling pathway and expression of Eya1, which in humans is involved in branchio-oto-renal syndrome."
explanation: >-
Names the downstream effectors through which HOXA2 shapes the pinna;
the authors qualify this as partial control.
downstream:
- target: Bilateral Microtia
description: >-
Failure of pinna morphogenesis presents clinically as bilateral microtia.
causal_link_type: DIRECT
evidence:
- reference: PMID:24067355
reference_title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Thus, Hoxa2 loss- and gain-of-function approaches in mice provide a suitable model to investigate the molecular aetiology of microtia and auricle duplication."
explanation: >-
The authors position the Hoxa2 auricular phenotype as the model of human
microtia aetiology.
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Based on the abnormalities observed in this family, the disease was categorized as microtia grade II.
explanation: >-
Direct clinical classification of the original family.
- target: Thickened Helices
description: >-
Abnormal auricular morphogenesis includes the thickened helices observed in the dominant family.
causal_link_type: DIRECT
evidence:
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
All five affected family members had small, malformed ears with a thickened helix and a superficial
postauricular sulcus (Fig. 1B).
explanation: >-
Clinical morphology in five enrolled affected members of the p.Gln235* family.
- target: Underdeveloped Antitragus
description: >-
Antitragal underdevelopment is one component of the documented auricular dysplasia.
causal_link_type: DIRECT
evidence:
- reference: url:https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
reference_title: https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
underdeveloped antitragus, serpiginous antihelix stem, deep incisura between tragus and antitragus
with a laterally dislocated hypoplastic lobe.
explanation: >-
Proband morphology from the author thesis describing the same p.Glu224* pedigree later reported in
PMID:27503514; this is not an additional family.
- name: Mis-Attachment of the Extrinsic Tongue and Hyoid Muscles
biological_scale: TISSUE
description: >-
In Hoxa2 mutant mice the attachments and trajectories of the extrinsic
tongue and hyoid muscles are abnormal. The abnormal trajectory of two of
them, the styloglossus and the stylohyoideus, blocks the attachment of the
hyoglossus to the greater horn of the hyoid, and that blocked attachment
correlated exactly with the presence of cleft palate in those animals. The
node is mouse-derived; no comparable observation has been reported in
HOXA2-mutant patients, in whom tongue and hyoid muscle anatomy has not been
described.
biological_processes:
- preferred_term: muscle attachment
modifier: ABNORMAL
term:
id: GO:0016203
label: muscle attachment
locations:
- preferred_term: extrinsic muscle of tongue
term:
id: UBERON:0001575
label: extrinsic muscle of tongue
- preferred_term: hyoglossus muscle
term:
id: UBERON:0001572
label: hyoglossus muscle
- preferred_term: hyoid bone greater horn
term:
id: UBERON:0003997
label: hyoid bone greater horn
evidence:
- reference: PMID:10529419
reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "We also uncovered multiple defects in the attachments and trajectories of the extrinsic tongue and hyoid muscles in Hoxa2 mutants."
explanation: >-
Records the muscle attachment and trajectory defects this node
represents, in Hoxa2 mutants.
- reference: PMID:10529419
reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "the abnormal trajectory of two of these muscles, the styloglossus and the stylohyoideus, blocked the attachment of the hyoglossus to the greater horn of the hyoid, which in turn correlated exactly with the presence of cleft palate in Hoxa2 mutants"
explanation: >-
Names the specific muscles involved and reports the exact correlation
between the blocked hyoglossus attachment and cleft palate, which is the
observation - as distinct from the interpretation on the next node.
downstream:
- target: Abnormal Tongue Posture Obstructing Palatal Shelf Closure
description: >-
Barrow and Capecchi's interpretation of the correlation: the hyoglossus,
unable to reach the greater horn, cannot depress the lateral edges of the
tongue. Support for the link is the rescue arm - restoring the attachment
in Hoxa1/Hoxa2 double mutants restores palatal closure over a flattened
tongue - rather than direct observation of tongue posture in the single
mutants.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:10529419
reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "We show that two compensatory defects, associated with the loss of Hoxa1 function, restore normal attachment of the hyoglossus to the greater horn thereby allowing the palatal shelves to lift and fuse above the flattened tongue."
explanation: >-
The rescue: restoring the hyoglossus attachment restores both the
flattened tongue and palatal shelf fusion, tying this node to the next.
directness: INDIRECT
- name: Abnormal Tongue Posture Obstructing Palatal Shelf Closure
biological_scale: TISSUE
description: >-
The proposed mechanical consequence, stated by its authors as a suggestion
rather than an observation: with the hyoglossus unable to depress the
lateral edges of the tongue, the tongue adopts an abnormal posture that
blocks closure of the palatal shelves. It is not the only published account
of the Hoxa2 cleft - see the
hoxa2_cleft_palate_tongue_versus_intrinsic_palate discussion and the
Intrinsic Palatal Shelf Fusion Defect node - and neither account has been
tested in a human patient.
biological_processes:
- preferred_term: secondary palate development
modifier: ABNORMAL
term:
id: GO:0062009
label: secondary palate development
locations:
- preferred_term: tongue
term:
id: UBERON:0001723
label: tongue
- preferred_term: secondary palatal shelf
term:
id: UBERON:0005619
label: secondary palatal shelf
evidence:
- reference: PMID:10529419
reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "We suggest that the hyoglossus, whose function is to depress the lateral edges of the tongue, when unable to make its proper attachment to the greater horn of the hyoid, forces the tongue to adopt an abnormal posture which blocks closure of the palatal shelves."
explanation: >-
The proposal this node represents, quoted in full so that its status as
the authors' suggestion is visible in the evidence itself.
downstream:
- target: Cleft Palate
description: >-
Shelves that do not close leave a cleft. In Hoxa1/Hoxa2 double mutants,
where the hyoglossus attachment is restored, the penetrance of cleft
palate falls sharply - the experimental result that ties the obstruction
to the cleft.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:10529419
reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Unexpectedly, in Hoxa1/Hoxa2 double mutants, the penetrance of cleft palate is dramatically reduced."
explanation: >-
Restoring the attachment sharply reduces the cleft, which is what makes
this edge causal rather than merely correlative.
directness: INDIRECT
- name: Intrinsic Palatal Shelf Fusion Defect
biological_scale: TISSUE
description: >-
A second, independent route to the same cleft. Hoxa2 is expressed in the
developing palate itself between E12.5 and E15.5, and Hoxa2-null palatal
shelves cultured in the absence of the tongue fuse at lower rates than
heterozygous or wild-type shelves, as do shelves in which Hoxa2 is knocked
down with antisense constructs. Null palates show an overall increase in
cell proliferation, and Hoxa2 represses Msx1, Bmp4, Barx1 and Ptx1 within
the palate. On the authors' reading the mouse cleft is therefore not solely
secondary to the tongue. Whether either route operates in HOXA2-mutant
humans is unknown.
biological_processes:
- preferred_term: secondary palate development
modifier: ABNORMAL
term:
id: GO:0062009
label: secondary palate development
locations:
- preferred_term: secondary palatal shelf
term:
id: UBERON:0005619
label: secondary palatal shelf
evidence:
- reference: PMID:19653318
reference_title: Hoxa2 plays a direct role in murine palate development.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "we detected Hoxa2 expression in the developing palate at both the mRNA and protein levels between embryonic day (E) 12.5 and E15.5"
explanation: >-
Hoxa2 is expressed in the palate itself, the precondition for a route
that does not run through the tongue.
- reference: PMID:19653318
reference_title: Hoxa2 plays a direct role in murine palate development.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Organ cultures of Hoxa2(-/-) palates maintained in the absence of the tongue showed decreased fusion rates than either Hoxa2(+/-) or Hoxa2(+/+) palate cultures."
explanation: >-
Palatal shelves fuse less well without Hoxa2 even when the tongue is
removed from the system - explant culture, hence IN_VITRO.
- reference: PMID:19653318
reference_title: Hoxa2 plays a direct role in murine palate development.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "These results demonstrate the cleft palate phenotype of Hoxa2 null embryos is not solely due to abnormal tongue musculature, and indicate a direct role of Hoxa2 in regulating murine palatogenesis."
explanation: >-
The authors' own conclusion that the tongue route is not the whole
account, which is why this node is curated alongside it rather than
instead of it.
downstream:
- target: Cleft Palate
description: >-
The explant and mouse findings support a palate-intrinsic contribution to clefting, but do not establish
its quantitative contribution or demonstrate the corresponding intermediate in affected humans.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:19653318
reference_title: Hoxa2 plays a direct role in murine palate development.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "These results demonstrate the cleft palate phenotype of Hoxa2 null embryos is not solely due to abnormal tongue musculature, and indicate a direct role of Hoxa2 in regulating murine palatogenesis."
explanation: >-
The authors' own conclusion that the tongue route is not the whole
account, which is why this node is curated alongside it rather than
instead of it.
directness: INDIRECT
phenotypes:
- name: Bilateral Microtia
category: Craniofacial
description: >-
Bilateral auricular malformation is the characteristic feature in recessive and dominant pedigrees. The
original recessive family was classified as grade II microtia, with recognizable helix, tragus and antitragus.
Severity and detailed morphology differ between families.
phenotype_term:
preferred_term: Bilateral microtia
term:
id: HP:0008551
label: Microtia
laterality: BILATERAL
notes: >-
Pedigree observations do not supply a population-level penetrance or frequency estimate.
evidence:
- reference: PMID:18394579
reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
explanation: Bilateral microtia in the recessive family.
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We ascertained a three-generation family with bilateral microtia and hearing loss segregating as an autosomal dominant trait."
explanation: Bilateral microtia in the first dominant family.
- reference: PMID:27503514
reference_title: Identification of a second HOXA2 nonsense mutation in a family with autosomal dominant non-syndromic microtia and distinctive ear morphology.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Here we describe a five-generation family with isolated bilateral microtia segregating as an autosomal dominant trait."
explanation: Bilateral microtia in a second dominant family.
- reference: PMID:32649979
reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Here, we collect two Chinese families with non-syndromic bilateral microtia."
explanation: Bilateral microtia in two further dominant families.
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Based on the abnormalities observed in this family, the disease was categorized as microtia grade II.
explanation: >-
Clinical grade in the original recessive family, not a universal grade for dominant microtia.
- name: Hearing Impairment
category: Auditory
description: >-
Hearing impairment varies across HOXA2 families. The original recessive family had prelingual severe to
profound mixed loss; the p.Gln235* dominant family had mild to severe mixed loss with one illustrated conductive-only
ear. In the p.Glu224* pedigree, the proband had normal otoacoustic emissions and the examined mother and
grandfather had normal audiometry.
phenotype_term:
preferred_term: Hearing impairment
term:
id: HP:0000365
label: Hearing impairment
notes: >-
Normal hearing in an affected family member does not exclude dominant HOXA2-related microtia.
evidence:
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We ascertained a three-generation family with bilateral microtia and hearing loss segregating as an autosomal dominant trait."
explanation: Hearing loss co-segregating in a dominant family.
- reference: PMID:32649979
reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "To date, only four HOXA2 mutations were reported in families with autosomal-recessive or dominant microtia, with or without hearing impairment."
explanation: >-
The literature summary records hearing impairment as a variable rather
than constant feature of HOXA2-related microtia.
quote_role: BACKGROUND
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Audiometric testing was performed on three of the affected family members and showed mild to severe bilateral
mixed hearing loss (Fig. 1C).
explanation: >-
Direct dominant-family audiology. The figure caption includes a mild conductive-only left ear in one
relative, so not every tested ear had both components.
- reference: url:https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
reference_title: https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
In both relatives audiometric testing had unremarkable results, as well as intraoral examination.
explanation: >-
Normal audiometry in the proband mother and maternal grandfather in the p.Glu224* pedigree; the thesis
and journal article describe the same family.
- name: Mixed Hearing Impairment
category: Auditory
description: >-
Mixed hearing impairment occurs in both recessive and dominant HOXA2 disease. It was symmetric and severe
to profound in the original recessive family and mild to severe in the tested p.Gln235* dominant relatives.
Ossicular abnormalities explain a conductive component. Unilateral inner-ear agenesis explains an anatomic
substrate in one recessive ear, but does not resolve the sensorineural component in other ears with normal
or unreported imaging.
phenotype_term:
preferred_term: Mixed hearing impairment
term:
id: HP:0000410
label: Mixed hearing impairment
laterality: BILATERAL
notes: >-
The dominant-family figure also documents a conductive-only ear; severity and audiological subtype should
be assessed per ear.
evidence:
- reference: PMID:18394579
reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
explanation: >-
Specifies the mixed, symmetrical, severe-to-profound character of the
recessive subtype's hearing loss.
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Audiometric testing was performed on three of the affected family members and showed mild to severe bilateral
mixed hearing loss (Fig. 1C).
explanation: >-
Direct dominant-family audiology. The figure caption includes a mild conductive-only left ear in one
relative, so not every tested ear had both components.
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
All four affected family individuals showed bilateral symmetric severe to profound mixed hearing impairment
affecting all frequencies and leading to a flat audiometric shape.
explanation: >-
The four affected members of the original recessive family; this severity should not be transferred to
all dominant cases.
- name: Cleft Palate
category: Craniofacial
subtype: AR-MHIC
description: >-
Partial cleft palate is documented in the original homozygous p.Gln186Lys family. Examined members of the
p.Gln235* and p.Glu224* dominant pedigrees had an intact palate or unremarkable intraoral examination.
Mouse null clefting supports developmental relevance but does not establish the specific mechanism of the
human cleft.
phenotype_term:
preferred_term: Cleft palate
term:
id: HP:0000175
label: Cleft palate
notes: >-
The subtype association is based on a small number of characterized pedigrees; it is not a universal genotype-phenotype
rule.
evidence:
- reference: PMID:18394579
reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
explanation: Partial cleft palate in the recessive family.
- reference: PMID:27503514
reference_title: Identification of a second HOXA2 nonsense mutation in a family with autosomal dominant non-syndromic microtia and distinctive ear morphology.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "HOXA2 biallelic mutations were also described in an inbreed family with autosomal recessive microtia, hearing impairment and incomplete cleft palate."
explanation: >-
The later article summarizes the same recessive family; it does not provide independent replication of
its cleft phenotype.
quote_role: BACKGROUND
- reference: PMID:7903600
reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Mice homozygous for a targeted mutation of the Hoxa-2 (Hox 1.11) gene are born with cleft palates and die within 24 hr of birth."
explanation: >-
Cleft palate in the homozygous mouse null provides model evidence for developmental relevance; the abstract
does not supply a penetrance denominator.
- name: External Auditory Canal Stenosis
description: >-
Three imaged recessive relatives had severe bilateral canal narrowing, with near-atresia of portions of
the bony canal. Canals were normally formed in the characterized p.Gln235* dominant family.
phenotype_term:
preferred_term: Stenosis of the external auditory canal
term:
id: HP:0000402
label: Stenosis of the external auditory canal
laterality: BILATERAL
evidence:
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
The results of high-resolution CT scanning confirmed that the external auditory canal was severely narrowed
bilaterally in the cartilaginous part of the auditory canal and almost atretic in part of the bony portion
in all patients.
explanation: >-
CT in the three examined recessive-family members, not every person with HOXA2-related disease.
subtype: AR-MHIC
- name: Abnormal Middle-Ear Ossicles
description: >-
Ossicular malformation and apparent fixation were imaged in three recessive relatives. Dominant-family
surgery documented abnormal stapes crura, absent stapedial tendon or a rigid ossicular chain.
phenotype_term:
preferred_term: Abnormality of the middle ear ossicles
term:
id: HP:0004452
label: Abnormality of the middle ear ossicles
evidence:
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
In all three patients the malformed ossicular chain seemed fixated by an incomplete atretic plate.
explanation: >-
CT findings in the three examined members of the recessive family; fixation was described as apparent
on imaging.
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
In individual II.2, the stapes was noted to have a thickened posterior crus and an absent anterior crus,
and the stapedial tendon was absent.
explanation: >-
Operative observation in one dominant-family member.
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Individual II.4 had a rigid ossicular chain.
explanation: >-
Operative observation in another member of the same dominant family.
- name: Unilateral Inner-Ear Aplasia
description: >-
Left inner-ear agenesis was confirmed by CT and MRI in one member of the recessive family. The other two
imaged relatives had normal inner-ear structures.
phenotype_term:
preferred_term: Aplasia of the inner ear
term:
id: HP:0011372
label: Aplasia of the inner ear
laterality: LEFT
evidence:
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
The inner-ear structures were normal in patients V: 2 and V: 3, but there were no inner-ear structures
on the left side for IV: 3.
explanation: >-
Unilateral inner-ear agenesis in one recessive-family member, with normal inner-ear anatomy in the other
two imaged relatives.
subtype: AR-MHIC
- name: Unilateral Facial Paresis
description: >-
Right facial paresis occurred in one examined member of the recessive family. Right facial-nerve hypoplasia
was suspected clinically; brain MRI was normal and did not confirm that explanation.
phenotype_term:
preferred_term: Unilateral facial palsy
term:
id: HP:0012799
label: Unilateral facial palsy
laterality: RIGHT
evidence:
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Individual number V: 2 also had a paresis on the right side of the face.
explanation: >-
Single affected relative; facial-nerve hypoplasia was suspected clinically but was not confirmed by brain
MRI.
subtype: AR-MHIC
- name: Thickened Helices
description: >-
The five enrolled affected members of the p.Gln235* dominant family had thickened helices and a superficial
postauricular sulcus.
phenotype_term:
preferred_term: Thickened helices
term:
id: HP:0000391
label: Thickened helices
evidence:
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
All five affected family members had small, malformed ears with a thickened helix and a superficial postauricular
sulcus (Fig. 1B).
explanation: >-
Clinical morphology in five enrolled affected members of the p.Gln235* family.
subtype: AD-Microtia
- name: Underdeveloped Antitragus
description: >-
The p.Glu224* proband had an underdeveloped antitragus as part of complex auricular dysplasia, including
a serpiginous antihelix and laterally displaced hypoplastic lobe. These detailed observations come from
the author thesis on the same published pedigree.
phenotype_term:
preferred_term: Underdeveloped antitragus
term:
id: HP:0011251
label: Underdeveloped antitragus
evidence:
- reference: url:https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
reference_title: https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
underdeveloped antitragus, serpiginous antihelix stem, deep incisura between tragus and antitragus with
a laterally dislocated hypoplastic lobe.
explanation: >-
Proband morphology from the author thesis describing the same p.Glu224* pedigree later reported in PMID:27503514;
this is not an additional family.
subtype: AD-Microtia
genetic:
- name: HOXA2 pathogenic variants
association: Causal
relationship_type: CAUSATIVE
presence: Pathogenic
gene_term:
preferred_term: HOXA2
term:
id: hgnc:5103
label: HOXA2
notes: >-
HOXA2 lies in the HOXA cluster at 7p15.2. Linkage and segregation established the recessive family; exome
or targeted sequencing identified dominant truncating alleles. The curated variants are examples, not an
exhaustive or current worldwide allele count. Haploinsufficiency is inferred, and the cited family studies
did not measure patient nonsense-mediated decay or a precise 50% protein reduction.
evidence:
- reference: PMID:18394579
reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Genome-wide linkage analysis localized the responsible gene to chromosome 7p14.3-p15.3 with a maximum multi-point LOD score of 4.17."
explanation: >-
Linkage to the HOXA cluster interval is the mapping evidence that
identified the gene.
- reference: PMID:32649979
reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Next generation sequencing identified two heterozygous nonsense HOXA2 mutations, one in each family."
explanation: >-
Two independent families carrying heterozygous nonsense alleles; p.Gln235* recurs from an earlier pedigree.
variants:
- name: p.Q186K homeodomain missense (recessive)
description: >-
Homozygous homeodomain missense p.Gln186Lys segregated in the original recessive family and was absent
from the reported control panels. The founding paper predicts altered DNA binding by homology modeling
but does not measure residual function. Protein notation avoids conflating historical nucleotide numbering
with a normalized transcript-specific HGVS description.
clinical_significance: PATHOGENIC
evidence:
- reference: PMID:18394579
reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The variant was not found in 231 Iranian and 109 Belgian control samples."
explanation: Control-panel absence supporting pathogenicity of p.Q186K.
- name: p.Q235* nonsense (dominant)
description: >-
A recurrent heterozygous nonsense allele, found independently in a
three-generation US family and in one of the two Chinese families.
clinical_significance: PATHOGENIC
evidence:
- reference: PMID:32649979
reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "One mutation (c.637A > T, p.Lys213*) is newly reported, while the other one (c.703C > T,p.Gln235*) is consistent with a previous report."
explanation: Documents recurrence of p.Gln235* across unrelated families.
- name: p.E224* nonsense (dominant)
description: >-
A heterozygous truncating allele segregating in all affected members of a
five-generation Italian family and absent from public databases.
clinical_significance: PATHOGENIC
evidence:
- reference: PMID:27503514
reference_title: Identification of a second HOXA2 nonsense mutation in a family with autosomal dominant non-syndromic microtia and distinctive ear morphology.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "In our family, sequence analysis detected a heterozygous protein truncating nonsense variant"
explanation: Defines the allele and its segregation.
- reference: url:https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
reference_title: https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Sanger analysis of the index patient (V:1) identified a previously unreported heterozygous variant
... NM_006735.3: c.670G>T, p.(Glu224*) ... in the second exon of the HOXA2 gene (Figure 17a).
explanation: >-
Primary thesis data identifying p.Glu224* in the same Italian pedigree as the journal article.
- name: p.Lys213* nonsense (dominant)
description: >-
Heterozygous p.Lys213* was found in one Chinese family; a dual-luciferase assay showed impaired HMX1
enhancer activation. The result supports loss of activity without establishing patient transcript decay.
clinical_significance: PATHOGENIC
evidence:
- reference: PMID:32649979
reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "One mutation (c.637A > T, p.Lys213*) is newly reported, while the other one (c.703C > T,p.Gln235*) is consistent with a previous report."
explanation: >-
Identifies the newly reported p.Lys213* allele and distinguishes it from recurrent p.Gln235*.
- reference: PMID:32649979
reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
supports: SUPPORT
evidence_source: IN_VITRO
directness: DIRECT
snippet: >-
Using dual luciferase reporter assays, we showed that both HOXA2 mutations have impaired activation
of the long-range enhancer of HMX1.
explanation: >-
Direct reporter result for p.Lys213* and p.Gln235*; impairment is not equivalent to a proven null effect.
prevalence:
- population: Worldwide
measure_type: CASES_IN_LITERATURE
notes: >-
Published evidence consists of a small number of pedigrees. No HOXA2-specific population prevalence is
established by these reports; all-cause microtia birth prevalence should not be assigned to this molecular
disorder.
evidence:
- reference: PMID:32649979
reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "To date, only four HOXA2 mutations were reported in families with autosomal-recessive or dominant microtia, with or without hearing impairment."
explanation: >-
A time-specific literature summary illustrates sparse pedigree evidence; it does not establish a current
worldwide family count or population prevalence.
quote_role: BACKGROUND
diagnosis:
- name: Clinical and audiological examination
description: >-
Inspect both auricles, ear canals, palate and facial movement, and obtain age-appropriate air- and bone-conduction
hearing thresholds. Mixed loss can occur in either inheritance subtype, and a normal hearing result does
not exclude dominant HOXA2 microtia. General microtia guidance recommends diagnostic ABR by two to three
months, followed by behavioral assessment as development permits.
evidence:
- reference: PMID:18394579
reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
explanation: >-
The clinical and audiological characterisation that defines the
presentation.
- reference: DOI:10.3389/fsurg.2022.944223
reference_title: Integrated microtia and aural atresia management
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
A diagnostic ABR should be performed as early as possible.
explanation: >-
General microtia diagnostic guidance, extrapolated to affected infants.
quote_role: REVIEW_SYNTHESIS
- reference: DOI:10.3389/fsurg.2022.944223
reference_title: Integrated microtia and aural atresia management
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
Air conduction and bone conduction testing should performed.
explanation: >-
The source recommends testing both pathways; the quotation preserves its grammatical omission.
quote_role: REVIEW_SYNTHESIS
- name: HOXA2 sequencing
description: >-
Identify a phenotype-compatible HOXA2 variant through targeted sequencing, a relevant hearing/craniofacial
panel or exome analysis, and test segregation where feasible. Interpret variant class, zygosity and family
phenotype together; a rare missense finding alone is not diagnostic. Heterozygous truncating alleles and
the original homozygous p.Gln186Lys allele have different inheritance and clinical associations.
evidence:
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Exome sequencing of affected family members detected only seven shared, rare, heterozygous, nonsynonymous variants, including one protein truncating variant, a HOXA2 nonsense change (c.703C>T, p.Q235*)."
explanation: Exome sequencing as the diagnostic route in a dominant family.
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Both of these nonsynonymous changes affect leucine residues with high evolutionary conservation; however,
each of these variants was also found in one control, indicating that either these variants are benign
or that these variants in combination with another undetected HOXA2 variant (possibly in a noncoding
portion of the gene) are responsible for microtia in these patients.
explanation: >-
The study itself did not establish causality for every rare missense variant; the proposed second-variant
explanation was untested.
- name: Temporal-bone imaging when clinically indicated
description: >-
CT characterizes canal narrowing, atretic plates and ossicles; MRI can assess inner-ear and neural anatomy.
The original recessive family had both ossicular abnormalities and one unilateral inner-ear agenesis. General
microtia guidance reserves routine reconstructive CT for surgical planning or suspected cholesteatoma rather
than the newborn period; unusual mixed loss or neurologic findings require individualized specialist assessment.
evidence:
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
The MRI of the auditory system in individual V: 3 was unremarkable for the inner ear and cerebellopontine
angle, but an MRI confirmed the inner-ear agenesis on the left side of individual IV: 3 as seen on CT-images.
explanation: >-
Human diagnostic imaging, with both normal and abnormal findings.
- reference: DOI:10.3389/fsurg.2022.944223
reference_title: Integrated microtia and aural atresia management
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
A CT scan of the temporal bone is not recommended in the newborn period.
explanation: >-
General microtia imaging guidance; this does not preclude individualized imaging for a specific diagnostic
concern.
quote_role: REVIEW_SYNTHESIS
treatments:
- name: Auricular Reconstruction
description: >-
Discuss observation, an external prosthesis, autologous cartilage reconstruction and alloplastic reconstruction
according to the individual goals and anatomy. Reconstruction is elective; coordinate its sequence with
any hearing implant or canal surgery. The recommendations come from general microtia care, not a HOXA2
outcome series.
therapeutic_modality: SURGERY
treatment_term:
preferred_term: auricular reconstruction
term:
id: NCIT:C25351
label: Reconstructive Surgery
target_mechanisms:
- target: Bilateral Microtia
treatment_effect: BYPASSES
description: >-
Reconstruction changes the visible auricular manifestation; it does not reverse the prenatal HOXA2 patterning
defect.
evidence:
- reference: DOI:10.3389/fsurg.2022.944223
reference_title: Integrated microtia and aural atresia management
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
In discussing the spectrum of reconstructive options, observation should be presented with associated
bene fits and drawbacks.
explanation: >-
General microtia/atresia guidance applied to the relevant HOXA2 phenotype; no HOXA2-specific treatment
effect is measured.
quote_role: REVIEW_SYNTHESIS
notes: >-
Observation is a legitimate choice. Choice and timing of reconstruction should account for the patient
wishes, hearing rehabilitation and surgical risks.
evidence:
- reference: DOI:10.3389/fsurg.2022.944223
reference_title: Integrated microtia and aural atresia management
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
In discussing the spectrum of reconstructive options, observation should be presented with associated
bene fits and drawbacks.
explanation: >-
General microtia/atresia guidance applied to the relevant HOXA2 phenotype; no HOXA2-specific treatment
effect is measured.
quote_role: REVIEW_SYNTHESIS
- name: Cleft Palate Repair
description: >-
For patients with cleft palate, craniofacial-team assessment determines whether and when palatoplasty is
indicated. General ACPA guidance places primary repair commonly at 9–14 months and ideally by 18 months,
with individual readiness and airway risk considered. The source supplies general care recommendations,
not genotype-specific efficacy.
therapeutic_modality: SURGERY
treatment_term:
preferred_term: cleft palate repair
term:
id: NCIT:C168380
label: Palatorrhaphy
target_mechanisms:
- target: Cleft Palate
treatment_effect: BYPASSES
description: >-
Palatoplasty restores palatal continuity and function after the congenital cleft has formed; it does
not correct the embryonic HOXA2 mechanism.
evidence:
- reference: url:https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
reference_title: https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
The goal of cleft palate surgery is to obtain normal function for speech and swallowing, as well as
to optimize airway and dental facial relations.
explanation: >-
General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report
HOXA2-specific outcomes.
quote_role: REVIEW_SYNTHESIS
notes: >-
Relevant to the cleft phenotype documented in AR-MHIC. Assess feeding, speech and the airway before and
after surgery; neither mouse cleft mechanism defines the surgical approach.
evidence:
- reference: url:https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
reference_title: https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
The goal of cleft palate surgery is to obtain normal function for speech and swallowing, as well as to
optimize airway and dental facial relations.
explanation: >-
General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report HOXA2-specific
outcomes.
quote_role: REVIEW_SYNTHESIS
- reference: url:https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
reference_title: https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
Primary surgery of cleft palate often occurs between 9-14 months of age. The timing should take into
account the patient and/or family readiness (physically and emotionally). Ideally, the cleft palate should
be closed by the age of 18 months.
explanation: >-
General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report HOXA2-specific
outcomes. Timing is individualized, rather than an outcome established for this genotype.
quote_role: REVIEW_SYNTHESIS
- name: Hearing Amplification
description: >-
Provide early hearing rehabilitation according to per-ear thresholds, canal anatomy and cochlear reserve.
General bilateral microtia/atresia guidance recommends amplification by four months and early intervention
by three to six months. Worn bone-conduction devices can bypass a narrowed or atretic canal; patients with
patent canals may use conventional amplification if appropriate. Mixed loss requires assessment of the
sensorineural component and device limits, rather than assuming normal cochlear function.
therapeutic_modality: DEVICE
treatment_term:
preferred_term: hearing amplification
term:
id: NCIT:C15747
label: Supportive Care
qualifiers:
- predicate:
preferred_term: medical device
term:
id: NCIT:C16830
label: Medical Device
value:
preferred_term: hearing aid
term:
id: NCIT:C183182
label: Hearing Aid
target_mechanisms:
- target: Hearing Impairment
treatment_effect: BYPASSES
description: >-
Amplification improves access to sound within the usable cochlear reserve. Bone conduction bypasses canal
and middle-ear transmission abnormalities but does not repair inner-ear agenesis or restore intrinsic
cochlear function.
evidence:
- reference: DOI:10.3389/fsurg.2022.944223
reference_title: Integrated microtia and aural atresia management
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
Diagnostic audiological assessment should be completed by 2 – 3 months of age and the infant provided
with hearing ampli fication by 4 months of age and enrolled in early intervention (EI) by 3 – 6 months
of age to optimize speech and language development.
explanation: >-
General microtia/atresia guidance applied to the relevant HOXA2 phenotype; no HOXA2-specific treatment
effect is measured. The timing recommendation is for bilateral microtia with atresia.
quote_role: REVIEW_SYNTHESIS
notes: >-
Do not delay early hearing support while deciding on cosmetic ear reconstruction. Device and implant selection
requires current specialist assessment; historical regulatory age cutoffs in the 2022 guidance are not
generalized here.
evidence:
- reference: DOI:10.3389/fsurg.2022.944223
reference_title: Integrated microtia and aural atresia management
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
Diagnostic audiological assessment should be completed by 2 – 3 months of age and the infant provided
with hearing ampli fication by 4 months of age and enrolled in early intervention (EI) by 3 – 6 months
of age to optimize speech and language development.
explanation: >-
General microtia/atresia guidance applied to the relevant HOXA2 phenotype; no HOXA2-specific treatment
effect is measured. The timing recommendation is for bilateral microtia with atresia.
quote_role: REVIEW_SYNTHESIS
- reference: DOI:10.3389/fsurg.2022.944223
reference_title: Integrated microtia and aural atresia management
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
Clinicians should encourage early use of these worn bone conduction devices for infants with CHL.
explanation: >-
General microtia/atresia guidance applied to the relevant HOXA2 phenotype; no HOXA2-specific treatment
effect is measured.
quote_role: REVIEW_SYNTHESIS
- name: Speech and Language Therapy
description: >-
Assess speech and language development in either subtype when hearing impairment or a palatal defect is
present. Coordinate early intervention, educational support and targeted therapy. Speech therapy can address
learned articulation errors; structural velopharyngeal dysfunction requires a separate surgical or prosthetic
assessment.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: speech and language therapy
term:
id: NCIT:C159273
label: Speech Language Therapy
evidence:
- reference: url:https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
reference_title: https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
The need for speech and/or language therapy for patients with a CL/P and/or other craniofacial difference,
as well as the recommended nature of that therapy, should be based on results of a formal speech and
language assessment and current best practices.
explanation: >-
General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report HOXA2-specific
outcomes.
quote_role: REVIEW_SYNTHESIS
- name: Genetic Counseling
description: >-
Discuss the identified genotype and variable phenotype with the family. When both parents carry a recessive
pathogenic allele, each pregnancy has a 25% probability of an affected child; a heterozygous parent with
a dominant pathogenic allele has a 50% transmission probability. These are Mendelian expectations conditional
on parental genotypes, not empirically measured penetrance. Severity and hearing status cannot be predicted
from transmission probability alone.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: Genetic Counseling
term:
id: NCIT:C15240
label: Genetic Counseling
evidence:
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Our data extend these conclusions and define HOXA2 haploinsufficiency as the first genetic cause for autosomal-dominant nonsyndromic microtia."
explanation: >-
Supports the inheritance mode. The stated recurrence probability is the Mendelian consequence of the
specified parental genotype, rather than a measured outcome in this pedigree.
directness: INDIRECT
- reference: PMID:18394579
reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
explanation: >-
Supports the inheritance mode. The stated recurrence probability is the Mendelian consequence of the
specified parental genotype, rather than a measured outcome in this pedigree.
directness: INDIRECT
- name: Feeding and nutrition support for cleft palate
description: >-
Assess feeding technique, intake, growth and hydration when cleft palate is present. A cleft team can select
an appropriate specialized feeding system and monitor weight gain. This addresses the general functional
risk of a cleft; a HOXA2-specific rate of feeding failure is not established.
therapeutic_modality: OTHER
treatment_term:
preferred_term: Supportive Care
term:
id: NCIT:C15747
label: Supportive Care
target_mechanisms:
- target: Cleft Palate
treatment_effect: BYPASSES
description: >-
A specialized feeding system compensates for impaired suction without closing the cleft.
evidence:
- reference: url:https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
reference_title: https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
Because infants with cleft palate cannot sustain the suction needed to maintain nutrition exclusively
from the breast or standard bottle, they typically require specialized feeding systems to achieve adequate
nutrition and hydration.
explanation: >-
General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report
HOXA2-specific outcomes. Feeding difficulty is a care risk, not an additional measured HOXA2 phenotype
frequency.
quote_role: REVIEW_SYNTHESIS
evidence:
- reference: url:https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
reference_title: https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: INDIRECT
snippet: >-
Because infants with cleft palate cannot sustain the suction needed to maintain nutrition exclusively
from the breast or standard bottle, they typically require specialized feeding systems to achieve adequate
nutrition and hydration.
explanation: >-
General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report HOXA2-specific
outcomes. Feeding difficulty is a care risk, not an additional measured HOXA2 phenotype frequency.
quote_role: REVIEW_SYNTHESIS
animal_models:
- name: Hoxa2 null mouse (Rijli 1993)
species: Mouse
genotype: Hoxa2 homozygous null (targeted disruption)
publication: PMID:7903601
description: >-
Homozygous targeted disruption causes perinatal death and loss of normal second-arch mesenchymal identity
despite preserved rhombomeric and neural crest segmentation. The source supports an identity defect; normal
migration and survival are not separately demonstrated by the cached abstract.
modeled_mechanisms:
- target: Loss of Second Pharyngeal Arch Neural Crest Identity
relationship: RECAPITULATES
fidelity: HIGH
description: >-
The model defines the identity-assignment lesion this node represents.
limitations: >-
A complete homozygous null differs from human heterozygous truncating alleles and homozygous p.Gln186Lys.
Residual function of the human missense allele has not been measured in the cited family study.
readouts:
- name: Second-arch neural crest identity
target: Loss of Second Pharyngeal Arch Neural Crest Identity
direction: ALTERED
interpretation: >-
Second-arch crest adopts first-arch identity, the defining readout of
the selector-gene lesion.
evidence:
- reference: PMID:7903601
reference_title: "A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "While rhombomeric and neural crest cell (NCC) segmentation was not affected, mesenchymal NCC derivatives of the second arch were lacking, and second arch mesenchymal NCC identity was changed to first arch identity, resulting in homeotic transformation of second to first arch skeletal elements."
explanation: The identity-change readout behind this link.
evidence:
- reference: PMID:7903601
reference_title: "A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "The ground pattern program appears to be modified in the mouse first arch by a Hox-independent process, whereas Hoxa-2 acts as a selector gene in the second arch."
explanation: >-
Establishes the model as informative for HOXA2's second-arch selector
function.
- name: Hoxa-2 null mouse (Gendron-Maguire 1993)
species: Mouse
genotype: Hoxa-2 (Hox 1.11) homozygous targeted mutation
publication: PMID:7903600
description: >-
An independent null allele reported simultaneously. Homozygotes are born
with cleft palate and die within 24 hours, with duplicated middle-ear
ossification centres and a second Meckel's cartilage beside the otic
capsule.
modeled_mechanisms:
- target: Homeotic Transformation of Second-Arch Skeletal Derivatives
relationship: RECAPITULATES
fidelity: MODERATE
description: >-
Defines the complete-null mouse skeletal homeosis, including duplicated middle-ear ossification centers.
limitations: >-
The perinatally lethal complete-null phenotype is more extensive than the observed human ossicular dysplasia.
Human imaging and surgery do not establish an equivalent homeotic duplication.
readouts:
- name: Middle-ear ossification centre duplication
target: Homeotic Transformation of Second-Arch Skeletal Derivatives
direction: INCREASED
interpretation: >-
Duplicated ossification centres are the skeletal signature of
second-to-first arch transformation.
evidence:
- reference: PMID:7903600
reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Analysis of stained skeletons revealed that homozygous mutant animals contained multiple cranial skeletal defects, including a duplication of the ossification centers of the bones of the middle ear."
explanation: The skeletal readout behind this link.
evidence:
- reference: PMID:7903600
reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Skeletal elements normally derived from the second arch were absent in the mutants."
explanation: >-
Establishes the model as informative for loss of second-arch skeletal
derivatives.
- target: Cleft Palate
relationship: RECAPITULATES
fidelity: MODERATE
description: >-
The mouse null has cleft palate, providing a phenotypic correspondence to the original recessive human
family.
limitations: >-
The complete-null mouse is perinatally lethal, whereas the original human recessive family has a partial
cleft and viable affected relatives. This does not establish normal long-term survival for every possible
human genotype.
readouts:
- name: Palatal closure
target: Cleft Palate
direction: ABOLISHED
interpretation: >-
Homozygous null mice were reported with cleft palate; the cached abstract does not provide a denominator
for penetrance.
evidence:
- reference: PMID:7903600
reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Mice homozygous for a targeted mutation of the Hoxa-2 (Hox 1.11) gene are born with cleft palates and die within 24 hr of birth."
explanation: The palatal readout behind this link.
evidence:
- reference: PMID:7903600
reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Mice homozygous for a targeted mutation of the Hoxa-2 (Hox 1.11) gene are born with cleft palates and die within 24 hr of birth."
explanation: >-
Establishes the model as informative for the palatal phenotype of the
recessive subtype.
- name: Hoxa1/Hoxa2 double mutant mouse (Barrow 1999)
species: Mouse
genotype: Compound targeted allele disrupting both of the linked genes Hoxa1 and Hoxa2
publication: PMID:10529419
description: >-
A single allele disrupting both linked genes, analysed against the single
mutants. Some double-mutant craniofacial defects are additive combinations
of the single-mutant ones and others appear only in the double mutant. The
result that matters here is a rescue: compensatory defects associated with
loss of Hoxa1 restore the hyoglossus attachment that is blocked in Hoxa2
mutants, and the penetrance of cleft palate falls sharply.
modeled_mechanisms:
- target: Mis-Attachment of the Extrinsic Tongue and Hyoid Muscles
relationship: RESCUES
fidelity: MODERATE
description: >-
Loss of Hoxa1 on the Hoxa2-mutant background restores normal attachment
of the hyoglossus to the greater horn of the hyoid.
limitations: >-
The rescue is by a second mutation rather than by restoring Hoxa2 or by
any treatment, so it establishes that the palate depends on the
attachment without showing how the attachment is normally specified. It
is also a mouse result with no human counterpart.
readouts:
- name: Hyoglossus attachment to the greater horn of the hyoid
target: Mis-Attachment of the Extrinsic Tongue and Hyoid Muscles
direction: RESTORED
interpretation: >-
The attachment blocked in Hoxa2 single mutants is made again in the
double mutants.
evidence:
- reference: PMID:10529419
reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "We show that two compensatory defects, associated with the loss of Hoxa1 function, restore normal attachment of the hyoglossus to the greater horn thereby allowing the palatal shelves to lift and fuse above the flattened tongue."
explanation: The attachment readout behind this link.
evidence:
- reference: PMID:10529419
reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "To understand how these two genes function together in craniofacial development, an allele was generated that disrupts both of these linked genes."
explanation: >-
Identifies the compound allele that makes this model informative for
the muscle-attachment node.
- target: Cleft Palate
relationship: RESCUES
fidelity: MODERATE
description: >-
Restoring the hyoglossus attachment sharply reduces the penetrance of
cleft palate, which is the experimental support for treating the muscle
defect as causal rather than coincidental.
limitations: >-
Penetrance falls but the abstract does not report how far, and the rescue
is genetic. It also does not exclude the palate-intrinsic route reported
by Smith and colleagues, which was measured in explant culture rather
than in this model.
readouts:
- name: Cleft palate penetrance
target: Cleft Palate
direction: DECREASED
interpretation: >-
The cleft that Hoxa2 single mutants show is much less penetrant once
the attachment is restored; the abstract does not give the figures.
evidence:
- reference: PMID:10529419
reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Unexpectedly, in Hoxa1/Hoxa2 double mutants, the penetrance of cleft palate is dramatically reduced."
explanation: The palatal readout behind this link.
evidence:
- reference: PMID:10529419
reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "We show that two compensatory defects, associated with the loss of Hoxa1 function, restore normal attachment of the hyoglossus to the greater horn thereby allowing the palatal shelves to lift and fuse above the flattened tongue."
explanation: >-
Ties the restored attachment to restored palatal closure, which is what
makes the model informative for the cleft.
- name: Conditional Hoxa2 inactivation mouse (Minoux 2013)
species: Mouse
genotype: Conditional Hoxa2 inactivation at early versus late gestational stages, plus conditional ectopic Hoxa2 in first-arch neural crest
publication: PMID:24067355
description: >-
Stage-specific conditional inactivation separates the auricular phenotype
from the lethal null. Early inactivation abolishes the auricle and
duplicates the external auditory canal; late inactivation yields a
hypomorphic auricle that the authors take to mimic the human HOXA2 mutant
condition. The reciprocal gain-of-function experiment - ectopic Hoxa2 in
first-arch crest - duplicates the pinna and eliminates the canal.
modeled_mechanisms:
- target: Failed Auricular Morphogenesis
relationship: RECAPITULATES
fidelity: HIGH
description: >-
Late inactivation produces auricular hypoplasia resembling the human phenotype. Fate mapping defines
the Hoxa2-expressing territory examined in the mouse study.
limitations: >-
Mouse and human pinna morphology differ substantially, and the model's
resemblance to the human condition is the authors' assessment rather than
a quantified comparison.
readouts:
- name: Auricle size and presence by stage of Hoxa2 inactivation
target: Failed Auricular Morphogenesis
direction: DECREASED
interpretation: >-
Auricular severity tracks the developmental stage at which Hoxa2 is
removed, from complete absence to hypoplasia.
evidence:
- reference: PMID:24067355
reference_title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "In mice, Hoxa2 inactivation at early gestational stages results in external auditory canal (EAC) duplication and absence of the auricle, whereas its late inactivation results in a hypomorphic auricle, mimicking the human HOXA2 mutant condition."
explanation: The stage-dependent auricular readout behind this link.
- name: Pinna lineage by genetic fate mapping
target: Failed Auricular Morphogenesis
direction: ALTERED
interpretation: >-
The investigators trace the auricular territory they call pinna to second-arch mesenchyme; the review
literature notes that including the tragus and root changes the anatomical scope.
evidence:
- reference: PMID:24067355
reference_title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "By genetic fate mapping we found that the mouse auricle (or pinna) derives from the Hoxa2-expressing neural crest-derived mesenchyme of the second pharyngeal arch, and not from a composite of first and second arch mesenchyme as previously proposed based on morphological observation of human embryos."
explanation: The lineage readout behind this link.
evidence:
- reference: PMID:24067355
reference_title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Thus, Hoxa2 loss- and gain-of-function approaches in mice provide a suitable model to investigate the molecular aetiology of microtia and auricle duplication."
explanation: >-
The authors' own statement that the model is suitable for the human
aetiology this node represents.
- name: Hoxa2 hypomorphic dosage-series mouse
species: Mouse
genotype: Hypomorphic Hoxa2 allele combined with wild-type or null alleles
publication: PMID:11578867
description: >-
An allele with about 45% of wild-type transcriptional activity was combined with normal and null alleles
to create a dosage series. Second-arch development was more sensitive than hindbrain patterning, and proximal-caudal
arch regions were more sensitive than rostro-distal regions. This supports regional dose sensitivity without
assigning a residual activity to a human variant.
modeled_mechanisms:
- target: Loss of Second Pharyngeal Arch Neural Crest Identity
relationship: PERTURBS
model_scale: TISSUE
limitations: >-
An engineered transcriptional-dose series does not measure patient missense function or distinguish every
cause of human-mouse phenotypic divergence.
evidence:
- reference: PMID:11578867
reference_title: Different levels of Hoxa2 are required for particular developmental processes.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
directness: DIRECT
snippet: >-
Analysis of these embryos indicates that in general the hindbrain is more resistant to Hoxa2 deficiencies
than the second branchial arch.
explanation: >-
Different embryonic regions respond differently to experimental Hoxa2 dose.
- reference: PMID:11578867
reference_title: Different levels of Hoxa2 are required for particular developmental processes.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
directness: DIRECT
snippet: >-
We have created a Hoxa2 allele that is about 45% as active in transcription as its wild-type counterpart.
explanation: >-
Engineered mouse allele, not a measured residual level in a patient.
evidence:
- reference: PMID:11578867
reference_title: Different levels of Hoxa2 are required for particular developmental processes.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
directness: DIRECT
snippet: >-
We have created a Hoxa2 allele that is about 45% as active in transcription as its wild-type counterpart.
explanation: >-
Engineered mouse allele, not a measured residual level in a patient.
- reference: PMID:11578867
reference_title: Different levels of Hoxa2 are required for particular developmental processes.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
directness: DIRECT
snippet: >-
Analysis of these embryos indicates that in general the hindbrain is more resistant to Hoxa2 deficiencies
than the second branchial arch.
explanation: >-
Different embryonic regions respond differently to experimental Hoxa2 dose.
discussions:
- discussion_id: hoxa2_mouse_null_lethality_vs_human_viability
kind: HUMAN_MODEL_MISMATCH
prompt: >-
Why does complete Hoxa2 loss kill mice at birth with a full second-to-first
arch homeotic transformation, while human HOXA2 loss-of-function alleles
produce a viable, largely isolated ear malformation?
attaches_to:
- pathophysiology#Homeotic Transformation of Second-Arch Skeletal Derivatives
- animal_models#Hoxa2 null mouse (Rijli 1993)
- animal_models#Hoxa-2 null mouse (Gendron-Maguire 1993)
rationale: >-
The complete mouse null is perinatally lethal with extensive skeletal homeosis, whereas characterized human
heterozygous truncating and homozygous p.Gln186Lys genotypes are viable. Dose, developmental timing and
species differences may contribute. Mouse hypomorphic alleles establish dose sensitivity, but residual
activity of the human missense allele was not measured in the founding study. Human ossicular dysplasia
therefore should not be described as proven partial homeotic duplication.
evidence:
- reference: PMID:7903600
reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Mice homozygous for a targeted mutation of the Hoxa-2 (Hox 1.11) gene are born with cleft palates and die within 24 hr of birth."
explanation: The lethal mouse null phenotype at one end of the mismatch.
- reference: PMID:27503514
reference_title: Identification of a second HOXA2 nonsense mutation in a family with autosomal dominant non-syndromic microtia and distinctive ear morphology.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Here we describe a five-generation family with isolated bilateral microtia segregating as an autosomal dominant trait."
explanation: >-
A five-generation pedigree of viable, isolated human disease at the other
end of the mismatch.
- reference: PMID:24067355
reference_title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "In mice, Hoxa2 inactivation at early gestational stages results in external auditory canal (EAC) duplication and absence of the auricle, whereas its late inactivation results in a hypomorphic auricle, mimicking the human HOXA2 mutant condition."
explanation: >-
Shows that timing of Hoxa2 loss alone spans much of the severity gap,
which is part of the candidate resolution.
- discussion_id: hoxa2_sensorineural_component_unexplained
kind: KNOWLEDGE_GAP
prompt: >-
What explains the sensorineural component of hearing loss in HOXA2-affected ears without demonstrated inner-ear
agenesis?
attaches_to:
- phenotypes#Mixed Hearing Impairment
rationale: >-
The original recessive family includes one left inner-ear agenesis confirmed by CT and MRI, while two other
examined relatives had normal inner-ear structures despite mixed hearing loss. Mixed loss also occurs in
the p.Gln235* dominant family. Thus the gap is not absence of any human inner-ear characterization: the
unresolved question is why sensorineural dysfunction occurs in other ears, and how it relates to HOXA2
development.
evidence:
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
The inner-ear structures were normal in patients V: 2 and V: 3, but there were no inner-ear structures
on the left side for IV: 3.
explanation: >-
Unilateral inner-ear agenesis in one recessive-family member, with normal inner-ear anatomy in the other
two imaged relatives.
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
Audiometric testing was performed on three of the affected family members and showed mild to severe bilateral
mixed hearing loss (Fig. 1C).
explanation: >-
Direct dominant-family audiology. The figure caption includes a mild conductive-only left ear in one
relative, so not every tested ear had both components.
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
All four affected family individuals showed bilateral symmetric severe to profound mixed hearing impairment
affecting all frequencies and leading to a flat audiometric shape.
explanation: >-
The four affected members of the original recessive family; this severity should not be transferred to
all dominant cases.
- discussion_id: hoxa2_cleft_palate_tongue_versus_intrinsic_palate
kind: CONTROVERSY
prompt: >-
Is the Hoxa2-associated cleft palate secondary to abnormal tongue
musculature, intrinsic to the palatal shelves, or both?
attaches_to:
- pathophysiology#Abnormal Tongue Posture Obstructing Palatal Shelf Closure
- pathophysiology#Intrinsic Palatal Shelf Fusion Defect
- phenotypes#Cleft Palate
rationale: >-
Two mouse accounts are on record and they are not the same claim. Barrow
and Capecchi report that mis-attachment of the hyoglossus correlates
exactly with cleft palate in Hoxa2 mutants and suggest that the resulting
tongue posture blocks the shelves, with a genetic rescue in Hoxa1/Hoxa2
double mutants as support. Smith and colleagues report Hoxa2 expression in
the palate itself and reduced fusion of Hoxa2-null shelves cultured without
a tongue, and conclude explicitly that the cleft is not solely due to the
tongue musculature. The two are compatible - a mechanical obstruction and a
shelf-intrinsic fusion defect could both contribute - but their relative
contribution has not been quantified, and neither has been examined in a
HOXA2-mutant patient, in whom the cleft is partial rather than complete.
Until that is settled, this entry carries both nodes and asserts neither as
the mechanism of the human cleft.
evidence:
- reference: PMID:10529419
reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "We suggest that the hyoglossus, whose function is to depress the lateral edges of the tongue, when unable to make its proper attachment to the greater horn of the hyoid, forces the tongue to adopt an abnormal posture which blocks closure of the palatal shelves."
explanation: The tongue-musculature position, in its authors' own hedged wording.
- reference: PMID:19653318
reference_title: Hoxa2 plays a direct role in murine palate development.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "The cleft palate exhibited by Hoxa2 null murine embryos has been described as being secondary to abnormalities of tongue musculature, and Hoxa2 was presumed to not play a direct role in palate development."
explanation: >-
The second group's statement of the prior position, which is what they
set out to test.
quote_role: BACKGROUND
- reference: PMID:19653318
reference_title: Hoxa2 plays a direct role in murine palate development.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "These results demonstrate the cleft palate phenotype of Hoxa2 null embryos is not solely due to abnormal tongue musculature, and indicate a direct role of Hoxa2 in regulating murine palatogenesis."
explanation: The palate-intrinsic position, stated as a conclusion.
notes: >-
This entry covers the recessive microtia-hearing impairment-cleft palate presentation and dominant HOXA2-related
microtia as allelic subtypes of one developmental disorder. Cleft palate is documented in the original recessive
family, but phenotype breadth and hearing severity require individual assessment. Pedigree-based observations
do not support population frequency bands. General microtia/atresia and cleft-palate care recommendations
are extrapolated to the relevant manifestations; HOXA2-specific treatment outcomes have not been established
by the cited sources.
Source identification: American Cleft Palate Craniofacial Association, 2024 Parameters
of Care. Feeding, speech and palatal-surgery recommendations are general craniofacial guidance extrapolated
to the relevant HOXA2 phenotype. Francesca Piceci Sparascio, Study of molecular basis of Oculo-Auricolo-Vertebral-Spectrum,
Università di Foggia doctoral dissertation, academic year 2015–2016. The HOXA2 section on pages 68–71 describes
the p.Glu224* pedigree also reported in PMID:27503514. Full text of Alasti et al. 2008 (PMID:18394579; PMCID:PMC2427268).
The PMID cache supplies the abstract; this linked PMC cache supplies the clinical and imaging passages quoted
here. Full text of Cox et al. 2014 (PMID:24880027; PMCID:PMC4143470), used for the auricular lineage and
anatomical terminology discussion.
datasets: []
experimental_models:
- name: HOXA2 variant HMX1 enhancer reporter assay
experimental_model_type: OTHER
description: >-
Dual-luciferase assays compare enhancer activation by p.Lys213* and p.Gln235* variants. The accessible
abstract does not specify the host-cell identity, so no cell-line or tissue origin is inferred.
modeled_mechanisms:
- target: Impaired Transactivation of the Long-Range HMX1 Enhancer
relationship: MEASURES
model_scale: MOLECULAR
limitations: >-
An isolated reporter does not reproduce human auricular development or quantify clinical penetrance.
evidence:
- reference: PMID:32649979
reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
supports: SUPPORT
evidence_source: IN_VITRO
directness: DIRECT
snippet: >-
Using dual luciferase reporter assays, we showed that both HOXA2 mutations have impaired activation
of the long-range enhancer of HMX1.
explanation: >-
Variant-specific reporter assay for p.Lys213* and p.Gln235*.
evidence:
- reference: PMID:32649979
reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
supports: SUPPORT
evidence_source: IN_VITRO
directness: DIRECT
snippet: >-
Using dual luciferase reporter assays, we showed that both HOXA2 mutations have impaired activation of
the long-range enhancer of HMX1.
explanation: >-
Variant-specific reporter assay for p.Lys213* and p.Gln235*.
- name: Tongue-free Hoxa2 mutant palate organ culture
experimental_model_type: OTHER
description: >-
Null palatal shelves cultured without a tongue have reduced fusion; antisense Hoxa2 knockdown also reduces
fusion. This demonstrates an intrinsic component in the mouse system alongside the separate tongue-mechanics
hypothesis.
modeled_mechanisms:
- target: Intrinsic Palatal Shelf Fusion Defect
relationship: PARTIALLY_RECAPITULATES
model_scale: TISSUE
limitations: >-
Explant fusion rates do not quantify in-vivo penetrance or establish the relative mechanism of the human
partial cleft.
evidence:
- reference: PMID:19653318
reference_title: Hoxa2 plays a direct role in murine palate development.
supports: SUPPORT
evidence_source: IN_VITRO
directness: DIRECT
snippet: >-
Organ cultures of Hoxa2(-/-) palates maintained in the absence of the tongue showed decreased fusion
rates than either Hoxa2(+/-) or Hoxa2(+/+) palate cultures.
explanation: >-
Tongue-free mouse organ culture isolates a palate-intrinsic contribution.
evidence:
- reference: PMID:19653318
reference_title: Hoxa2 plays a direct role in murine palate development.
supports: SUPPORT
evidence_source: IN_VITRO
directness: DIRECT
snippet: >-
Organ cultures of Hoxa2(-/-) palates maintained in the absence of the tongue showed decreased fusion
rates than either Hoxa2(+/-) or Hoxa2(+/+) palate cultures.
explanation: >-
Tongue-free mouse organ culture isolates a palate-intrinsic contribution.
differential_diagnoses:
- name: FGF3-related labyrinthine aplasia, microtia and microdontia
disease_term:
preferred_term: deafness with labyrinthine aplasia, microtia, and microdontia
term:
id: MONDO:0012541
label: deafness with labyrinthine aplasia, microtia, and microdontia
description: >-
FGF3-related disease can share microtia and inner-ear agenesis. Microdontia and the broader pattern of
inner-ear malformation help distinguish it; molecular testing separates the disorders.
distinguishing_features:
- FGF3-associated microdontia and inner-ear agenesis contrast with variable inner-ear findings in HOXA2 families.
evidence:
- reference: PMID:23775976
reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
directness: DIRECT
snippet: >-
FGF3 (congenital deafness, inner ear agenesis, microtia, microdontia; MIM # 164950)
explanation: >-
Background clinical differential in the primary HOXA2 report.
quote_role: BACKGROUND
Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.
Remove fabricated cleft-palate mechanism; curate the two published mouse accounts · 2026-09-04T20:33:14Z · View source
Review of PR #10909 found a fabricated mechanism in an ungated prose field: the Cleft Palate Repair treatment's target_mechanisms description asserted that the cleft was caused by 'ectopic second-arch cartilage obstructing elevation of the palatal shelves'. No cited reference says this. All nine references cited in the entry were grepped for palate, cartilage, shelf, shelves, tongue, hyoglossus and hyoid: the only near neighbour is PMID:7903600's duplicated Meckel's cartilage beside the otic capsule, a middle-ear finding that says nothing about the palate, and PMID:7903600's statement that the mouse null is born with cleft palate, which is the fact and not the mechanism. The falcon deep-research report does not contain the claim either; its own wording is the hedged 'abnormal palate development provides a route to cleft palate'. The clause was removed and replaced with the two mouse accounts that are actually published, each curated as a pathophysiology node with quoted evidence. 1. Barrow and Capecchi 1999 (PMID:10529419, fetched via just fetch-reference): mis-attachment of the extrinsic tongue and hyoid muscles, with the abnormal trajectory of the styloglossus and stylohyoideus blocking the hyoglossus attachment to the greater horn of the hyoid, correlating exactly with cleft palate; and the authors' suggestion that the resulting tongue posture blocks palatal shelf closure. Curated as two nodes so that the observation and the interpretation carry separate evidence, with the Hoxa1/Hoxa2 double-mutant rescue as the support for the link. Added the double-mutant mouse as an animal model with two RESCUES links. 2. Smith et al. 2009 (PMID:19653318, found by PubMed search for HOXA2 AND palatogenesis): Hoxa2 expression in the palate itself, reduced fusion of Hoxa2-null shelves cultured without a tongue, and the authors' explicit conclusion that the cleft is not solely due to the tongue musculature. Curated as the Intrinsic Palatal Shelf Fusion Defect node hanging off HOXA2 Loss of Function. A CONTROVERSY discussion, hoxa2_cleft_palate_tongue_versus_intrinsic_palate, records that the two accounts are both mouse, are compatible, have not been weighed against each other, and have not been examined in a HOXA2-mutant patient. The entry now asserts neither as the mechanism of the human cleft. The downstream edge from Homeotic Transformation of Second-Arch Skeletal Derivatives to Cleft Palate was removed: no source links the skeletal transformation to the cleft. Its evidence, that the mouse null is born with cleft palate, is a genotype-level co-occurrence and was moved to the Cleft Palate phenotype, where the description already made that statement. Smaller prose corrections found in the same sweep: the treatment notes said 'seven cited references' and there are now nine; a model readout interpretation turned 'penetrance dramatically reduced' into 'most double mutants', which the abstract does not support; the HMX1 enhancer node stated Hoxa2-Hmx1 enhancer binding without the 'in mouse' qualifier the source carries; CL:0000008 carried a preferred_term broader than the ontology label; and the notes now record that the falcon report argued against lumping the dominant families and why that was not followed. Validation: just validate (schema, terms, references - 77/77 snippets verified), validate-terms, count-verified-snippets, check-entity-refs, check-duplicate-keys, check-causal-targets, check-enum-values, check-qualifier-terms, check-folded-hyphens, check-snippet-length, check-title-snippets, check-snippet-grading, validate-disorders. Pathograph wiring was checked by hand: no dangling bare-name targets, no node without an incoming edge except the root, and every phenotype is a target.
Review round 1 fixes: prevalence band, two ontology rebindings, deep-research pass, pathograph joins · 2026-09-04T18:08:31Z · View source
Addressed the CHANGES_REQUESTED review of 2026-09-04T06:58Z on PR #10909. All four blocking items fixed and all three suggestions taken, in one push. BLOCKING 1 (fixed). prevalence_class on the all-causes microtia birth-prevalence record was BAND_1_9_PER_100000 while the recorded interval is 10.0-12.5 per 100,000, so the whole interval sat above the band ceiling. Changed to BAND_1_5_PER_10000, which the schema defines as 1-9 per 10,000 equals 10-99 per 100,000. Rate numbers and notes unchanged; the arithmetic was already correct. BLOCKING 2 (fixed). Ran a falcon deep-research pass and committed research/Bilateral_Microtia-Deafness-Cleft_Palate_Syndrome-deep-research-falcon.md with its citations sidecar, artifact, and the eleven DOI reference caches the run fetched. 30 citations, 11 of 11 references verified at 0.0 confabulation, 2 on topic, 1 flagged off topic, 29 of 29 terms resolved. just preflight-dr against MONDO:0012854 returns PASS with HOXA2 mentioned 54 times. The report's outcome is recorded in the entry-level notes: - One real gap found. Meddaugh and Zambrano 2020 (PMID:31567444) is a sixth published HOXA2 family, a four-generation pedigree with microtia and variable hearing impairment, which the manual sweep missed. It cannot be curated as evidence: both the PubMed record and the DOI record are abstract-free, so the caches are title-only and there is no quotable sentence. Recorded in notes rather than added to references: as a tagged-but-not-mined citation, following the same reasoning the sibling hearing-loss entries use for the GeneReviews overview. The report attributes a truncating allele around Glu229 to that family; that is unverified and is explicitly not asserted anywhere in the entry. Softened the two family-count statements (the Bilateral Microtia phenotype notes and the CASES_IN_LITERATURE prevalence notes) so they read as counts of citable families rather than of the literature, without moving the ULTRA_RARE band. - One lead checked and not taken. Wilderman et al. 2024 describe a roughly 600-kb noncoding global control region between NPVF and NFE2L3 driving anterior HOXA expression, whose mouse deletion produces orofacial clefts resembling the Hoxa2 null. That is upstream regulatory architecture for the cluster, not a HOXA2 lesion in any reported patient with this disease; the report says so itself. Recorded as a candidate for a future regulatory-variant node. - One independent confirmation. The report's management citations are all general microtia and aural-atresia literature - international consensus recommendations, integrated atresia management, a national treatment guideline - and none is HOXA2-specific. That corroborates the treatments section's existing statement that no HOXA2-specific outcome data exists, which had rested on the curator's own search. BLOCKING 3 (fixed). Rebound the Loss of Second Pharyngeal Arch Neural Crest Identity cell type from CL:0000333 migratory neural crest cell to CL:0000008 migratory cranial neural crest cell, which matches the node's own preferred_term. Verified through OAK and it passes validate-terms and dynamic-enum membership; both CURIEs were already cached so no cache CSV changed. BLOCKING 4 (fixed). Rebound the Auricular Reconstruction treatment term from the generic NCIT:C15329 Surgical Procedure to NCIT:C25351 Reconstructive Surgery. Confirmed through OAK that NCIT:C25351 has NCIT:C25218 Clinical Intervention or Procedure among its ancestors, so it is a valid TreatmentTerm. SUGGESTION (taken). Added target_mechanisms to the two therapeutic treatments, using bare pathograph names rather than entity-reference syntax. Auricular Reconstruction targets the Bilateral Microtia phenotype and Hearing Amplification targets the Hearing Impairment phenotype, both with treatment_effect: BYPASSES, because neither corrects the developmental lesion. Verified with dismech.graph.build_causal_graph that both edges resolve and orphan_targets is empty. Neither link carries evidence, and each treatment's notes now says why: no published series reports outcomes in HOXA2-mutant patients, so a quote would have to come from the general microtia literature and would attribute to this disease something no source says about it. SUGGESTION (taken). Replaced the ambiguous attaches_to: animal_models#Mouse on the HUMAN_MODEL_MISMATCH discussion, which resolved against species and so pointed at all three mouse models indistinguishably, with the two specific model names the mismatch concerns: Hoxa2 null mouse (Rijli 1993) and Hoxa-2 null mouse (Gendron-Maguire 1993). Both resolve under check-entity-refs. SUGGESTION (taken, in a different form than proposed). Bilaterality is now carried on the Bilateral Microtia phenotype_term's preferred_term, which reads Bilateral microtia against the HP:0008551 Microtia binding. A laterality qualifier was considered and rejected: HP has no non-obsolete bilateral-microtia term (HP:0040111 is obsolete), no dismech entry uses a laterality predicate-value qualifier so there is no precedent to follow, and CLAUDE.md records that qualifier terms are invisible to validate-terms and have previously hidden 32 wrong bindings. Carrying the specificity in preferred_term is the pattern the Ontology Term Contract endorses. Validation. just validate, validate-terms, count-verified-snippets (57/57), check-entity-refs, check-duplicate-keys, check-causal-targets, check-enum-values, check-qualifier-terms all pass on the file. Whole-KB check-folded-hyphens, check-title-snippets, check-snippet-length and check-snippet-grading report no new divergences. check-source-defect-claims reports nothing for this entry. qc-deep-research on the new report shows 11 cited references not consumed into the entry, which is an advisory census and well inside the normal range. No cache/**.csv changed.
Question: You are an expert researcher providing comprehensive, well-cited information.
Provide detailed information focusing on: 1. Key concepts and definitions with current understanding 2. Recent developments and latest research (prioritize 2023-2024 sources) 3. Current applications and real-world implementations 4. Expert opinions and analysis from authoritative sources 5. Relevant statistics and data from recent studies
Format as a comprehensive research report with proper citations. Include URLs and publication dates where available. Always prioritize recent, authoritative sources and provide specific citations for all major claims.
Please provide a comprehensive research report on Bilateral Microtia-Deafness-Cleft Palate Syndrome covering all of the disease characteristics listed below. This report will be used to populate a disease knowledge base entry. Be thorough and cite primary literature (PMID preferred) for all claims.
For each section, suggested databases/resources are listed. These are the first places you should search for information on each topic.
Search first: OMIM, Orphanet, ICD-10/ICD-11, MeSH, PubMed
Search first: PubMed, Cochrane Library, UpToDate, clinical guidelines, ClinVar, ClinGen, GWAS Catalog, PheGenI, CTD, CDC, WHO, epidemiological databases
Search first: PubMed, Cochrane Library, clinical trial databases, GWAS Catalog, gnomAD, WHO, CDC, nutrition databases
Search first: CTD, PubMed, PheGenI, GxE databases
Search first: HPO (Human Phenotype Ontology), OMIM, Orphanet, PubMed, clinicaltrials.gov, MedDRA, SNOMED CT, DECIPHER, LOINC
For each phenotype, provide: - Phenotype type: symptoms, clinical signs, physical manifestations, behavioral changes, or laboratory abnormalities
For symptoms/signs: HPO, OMIM, Orphanet, PubMed For behavioral changes: HPO, DSM, RDoC (Research Domain Criteria), PubMed For laboratory abnormalities: LOINC, SNOMED CT, LabTests Online, PubMed - Phenotype characteristics: Search first: OMIM, Orphanet, HPO, PubMed - Age of symptom onset (neonatal, childhood, adult-onset, late-onset) - Symptom severity (mild, moderate, severe, variable) - Symptom progression (stable, progressive, episodic, fluctuating) - Frequency among affected individuals (percentage or qualitative) - Quality of life impact: Effects on daily functioning and well-being (per-phenotype when possible) Search first: EQ-5D database, SF-36, WHO QOL databases, PubMed - Suggest HPO (Human Phenotype Ontology) terms for each phenotype
Search first: OMIM, ClinVar, HGMD, Ensembl, NCBI Gene
Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth
Search first: DECIPHER, ClinVar, ECARUCA, UCSC Genome Browser
Search first: CTD (Comparative Toxicogenomics Database), TOXNET, PubMed, EPA databases
Search first: CDC databases, WHO, PubMed, NHANES
Search first: NCBI Taxonomy, ViPR, BV-BRC, MicrobeDB, GIDEON
Present this section as an ordered causal chain first, then the detail below. Open with a numbered sequence of mechanistic steps running from the initiating lesion (mutation, exposure, infection) to the clinical manifestation, one step per line, each naming what it causes next. State the causal verb explicitly ("leads to", "results in") and say where a step is inferred rather than demonstrated. Where the mechanism branches, show the branch. The categories below are a checklist of what to cover within those steps, not the organizing structure — a step may draw on several of them, and a category may contribute to several steps.
Search first: KEGG, Reactome, WikiPathways, PathBank, BioCyc
Search first: Gene Ontology (GO), Reactome, KEGG, PubMed
Search first: UniProt, PDB (Protein Data Bank), InterPro, Pfam, AlphaFold
Search first: KEGG, BioCyc, HMDB (Human Metabolome Database), BRENDA
Search first: ImmPort, Immunome Database, IEDB, Gene Ontology
Search first: PubMed, Gene Ontology, Reactome
Search first: BRENDA, UniProt, KEGG, OMIM, PubMed
Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth
For each mechanism, describe: - The causal chain from initial trigger to clinical manifestation - Which mechanisms are upstream vs downstream - What cell types and biological processes are involved - Suggest GO terms for biological processes and CL terms for cell types
Search first: Uberon, FMA (Foundational Model of Anatomy), OMIM, HPO, ICD-11, MeSH, SNOMED CT
Search first: Uberon, Human Protein Atlas, Cell Ontology, Human Cell Atlas, CellMarker, PanglaoDB
Search first: Gene Ontology (Cellular Component), UniProt, Human Protein Atlas
Search first: OMIM, Orphanet, HPO, PubMed
Search first: Disease registries, longitudinal cohort databases, natural history studies, PubMed, Orphanet, OMIM
Search first: Orphanet, CDC, WHO, GBD (Global Burden of Disease), national registries, SEER, disease registries
Search first: GTR (Genetic Testing Registry), GeneReviews, ClinGen
For each treatment, suggest NCIT (NCI Thesaurus) clinical-intervention terms where applicable.
Search first: CDC vaccine schedules, WHO immunization, FDA vaccine database
Search first: CDC, WHO, behavioral intervention databases, Cochrane Library
Search first: NSGC resources, ACMG guidelines, GeneReviews
Search first: Clinical guidelines, FDA approvals, PubMed
Search first: NCBI Taxonomy
Search first: VBO (Vertebrate Breed Ontology)
Search first: NCBI Gene
Structure your response as a comprehensive narrative organized by the sections above. For each section, provide: - Factual content with specific details (numbers, percentages, gene names, variant nomenclature) - Ontology term suggestions (HPO, GO, CL, UBERON, CHEBI, NCIT, MONDO) where applicable - Evidence citations with PMIDs - Direct quotes from abstracts to support key claims - Clear indication when information is not available or not applicable for this disease
This report will be used to populate a disease knowledge base entry with: - Pathophysiology descriptions with causal chains - Gene/protein annotations (HGNC, GO terms) - Phenotype associations (HP terms) with frequencies - Cell type involvement (CL terms) - Anatomical locations (UBERON terms) - Chemical entities (CHEBI terms) - Treatment annotations (NCIT terms) - Evidence items with PMIDs and exact abstract quotes - Epidemiology, prognosis, diagnostic, and prevention information - Animal model descriptions with phenotype recapitulation details
Bilateral microtia–deafness–cleft palate syndrome is an exceptionally rare congenital Mendelian disorder caused, in its defining family, by a homozygous missense variant in HOXA2. It is characterized by bilateral Marx type II microtia, prelingual symmetric severe-to-profound mixed hearing impairment, and partial/incomplete cleft palate. The entire syndrome-specific evidence base consists essentially of four affected relatives in one consanguineous Iranian family reported in 2008; unilateral cochlear absence was found in one person. Consequently, pedigree fractions must not be interpreted as population frequencies, and prevalence, penetrance outside that family, prognosis, and treatment-response statistics remain unknown. The association is catalogued as MONDO:0012854 and linked to HOXA2 in contemporary disease–target resources. (alasti2009geneticsofmicrotia pages 11-14, alasti2009geneticsofmicrotia pages 18-20, OpenTargets Search: Bilateral microtia-deafness-cleft palate syndrome-HOXA2)
| Domain | Syndrome-specific established evidence | Evidence basis | Confidence/limitations |
|---|---|---|---|
| Identity | Bilateral microtia-deafness-cleft palate syndrome; MONDO:0012854; HOXA2-associated Mendelian disorder. | Disease–target aggregation identifies HOXA2 as the sole associated target (OpenTargets Search: Bilateral microtia-deafness-cleft palate syndrome-HOXA2). | High for MONDO identity and HOXA2 association; other identifiers should not be inferred without direct database confirmation. |
| Human evidence base | Reported in one consanguineous Iranian pedigree with four affected individuals. | Original family report and subsequent HOX-disorder review (alasti2009geneticsofmicrotia pages 11-14, alasti2009geneticsofmicrotia pages 18-20). | Very limited: four relatives from one family; percentages calculated from this pedigree are not population frequencies. |
| Genetics | Autosomal-recessive segregation of homozygous HOXA2 p.Gln186Lys (p.Q186K), affecting a highly conserved homeodomain residue. | Primary linkage and sequencing study (alasti2009geneticsofmicrotia pages 11-14, alasti2009geneticsofmicrotia pages 18-20). | Strong segregation evidence in the original pedigree; historical variant interpretation predates current ACMG/AMP criteria, so a contemporary laboratory should reassess classification and transcript-level HGVS nomenclature. |
| Mapping and functional support | Linked to chromosome 7p14.3–p15.3 with maximum multipoint LOD 4.17; p.Q186K was absent from 231 Iranian and 109 Belgian controls. Structural modeling predicted loss of a homeodomain–DNA phosphate hydrogen bond and altered DNA binding. | Primary human genetic and computational study (alasti2009geneticsofmicrotia pages 11-14). | Strong linkage and rarity evidence; protein effect was modeled computationally rather than demonstrated with a syndrome-specific cellular functional assay. |
| Core phenotype | Congenital bilateral Marx type II microtia, prelingual symmetric severe-to-profound mixed hearing impairment, and partial/incomplete cleft palate. | Original report summarized in authoritative review (alasti2009geneticsofmicrotia pages 11-14). | High within the pedigree; penetrance and expressivity in unrelated families remain unknown. |
| Inner-ear involvement | Unilateral cochlear absence occurred in one affected individual, showing that inner-ear involvement is possible in addition to predominant external- and middle-ear disease. | Human clinical/imaging observation (alasti2009geneticsofmicrotia pages 11-14). | Moderate; single-patient observation and not a reliable frequency estimate. |
| Mechanism | Reduced HOXA2 homeobox transcription-factor function is inferred to impair second-pharyngeal-arch cranial-neural-crest identity and patterning, leading to malformed pinna and middle-ear skeletal structures; abnormal palate development provides a route to cleft palate. | Human variant modeling plus Hoxa2 mouse developmental studies (alasti2009geneticsofmicrotia pages 11-14, cox2014thegeneticsof pages 3-3, alasti2009geneticsofmicrotia pages 5-8). | Biologically compelling but partly inferred; the complete molecular chain has not been demonstrated in patient-derived cells or tissues. |
| Mouse-model evidence | Hoxa2-deficient mice lack pinnae, have transformed or duplicated middle-ear skeletal elements and a wide secondary-palate cleft, and die shortly after birth; ectopic expression experiments establish a dosage-sensitive role in pharyngeal-arch identity. | Knockout/ developmental evidence summarized in reviews and primary-model literature (alasti2009geneticsofmicrotia pages 11-14, cox2014thegeneticsof pages 3-3, cox2014thegeneticsof pages 3-4). | Strong developmental evidence, but null-mouse lethality and severity exceed the surviving human missense phenotype. |
| Diagnosis | Molecular confirmation should identify biallelic HOXA2 variants after detailed craniofacial examination and audiologic assessment; diagnostic ABR should be performed by 2–3 months, with air- and bone-conduction thresholds. Temporal-bone CT/MRI is selected according to age, anatomy, suspected inner-ear disease, and surgical planning. | HOXA2 family evidence plus general microtia/atresia expert guidance (truong2022integratedmicrotiaand pages 4-6, truong2022integratedmicrotiaand pages 2-4, paul2021congenitalabnormalitiesassociated pages 3-3). | Genetic testing is syndrome-directed; audiologic and imaging pathways are extrapolated because no syndrome-specific diagnostic guideline exists. |
| Management | Phenotype-directed multidisciplinary care may include early amplification and speech/language intervention, bone-conduction hearing systems when appropriate, anatomy-dependent atresia/hearing surgery, cleft-palate repair and speech therapy, and coordinated auricular reconstruction. | General microtia/atresia consensus and integrated-care recommendations (truong2022integratedmicrotiaand pages 4-6, zhang2019internationalconsensusrecommendations pages 2-3, truong2022integratedmicrotiaand pages 16-17, truong2022integratedmicrotiaand pages 1-2). | No HOXA2-specific outcome data; treatment must account for the mixed hearing loss and possible cochlear aplasia rather than assuming isolated conductive loss. |
| Epidemiology and natural history | Syndrome-specific prevalence, incidence, carrier frequency, sex ratio, life expectancy, and longitudinal progression are unknown. | Only one pedigree has established the recessive syndromic phenotype (alasti2009geneticsofmicrotia pages 11-14, alasti2009geneticsofmicrotia pages 18-20). | Very low epidemiologic certainty; general microtia prevalence or sex ratios must not be assigned to this syndrome. |
| Disease-modifying therapy and trials | No established pharmacologic, gene, RNA, or cell therapy and no syndrome-specific interventional trial were identified; current care treats hearing, palate, speech, and reconstructive consequences. | Available disease evidence and microtia management literature (OpenTargets Search: Bilateral microtia-deafness-cleft palate syndrome-HOXA2, truong2022integratedmicrotiaand pages 4-6, zhang2019internationalconsensusrecommendations pages 2-3). | Search-dependent negative finding; broader ear-reconstruction or hearing-device studies are not evidence for correction of the HOXA2 developmental lesion. |
| 2024 development | A distant approximately 600-kb craniofacial global control region was shown to interact with anterior HOXA genes; deletion in mice produced highly penetrant skull defects and orofacial clefts resembling Hoxa2-null phenotypes, while human copy-number changes were associated with severe craniofacial abnormalities. | Human embryonic epigenomics, mouse deletion experiments, and human CNV cases (wilderman2024adistantglobal pages 13-13, wilderman2024adistantglobal pages 1-2). | Important HOXA regulatory insight, but not direct evidence that this control region causes the named p.Q186K recessive syndrome or changes current treatment. |
Table: This table separates observations established in the single reported HOXA2-associated pedigree from mouse-mechanistic evidence and clinical guidance extrapolated from broader microtia, hearing-loss, and cleft-care literature.
In this report, direct evidence means observations from the original human family; supportive human evidence means other HOXA2-related microtia families; model evidence means principally mouse developmental experiments; and extrapolated care means guidance for microtia/aural atresia, congenital hearing loss, or cleft palate generally. This distinction is essential because no syndrome-specific cohort, guideline, therapeutic trial, patient-derived model, or longitudinal natural-history study was identified.
The disorder is a congenital craniofacial and auditory developmental syndrome comprising:
The original article’s abstract described “a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate.” The report was published in April 2008 in The American Journal of Human Genetics as Alasti et al., “A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family,” DOI: https://doi.org/10.1016/j.ajhg.2008.03.014, PMID 18394579. An erratum appeared in September 2008, DOI: https://doi.org/10.1016/j.ajhg.2008.08.014; it did not alter the principal genetic result. (alasti2009geneticsofmicrotia pages 18-20, alasti2008amutationin pages 1-1)
Common names include bilateral microtia-deafness-cleft palate syndrome, HOXA2-related autosomal-recessive microtia, and microtia, hearing impairment, and cleft palate. “HOXA2-related disorder” is broader and also includes autosomal-dominant, usually nonsyndromic microtia with variable hearing impairment; those dominant conditions should not be merged with this recessive phenotype. Supportive reports show that heterozygous HOXA2 loss-of-function can cause dominant bilateral microtia and variable hearing loss without the defining cleft-palate phenotype. (meddaugh2020novelhoxa2variant pages 3-3)
The evidence is aggregated disease-level literature derived from a small family study, not EHR-derived individual-patient data.
The defining cause is a germline homozygous HOXA2 homeodomain missense variant, p.Gln186Lys (p.Q186K), segregating recessively in the Iranian pedigree. Genome-wide linkage mapped the locus to 7p14.3–p15.3, with a maximum multipoint LOD score of 4.17. The variant was absent from 231 Iranian and 109 Belgian controls—680 control chromosomes if all were diploid and unrelated. Structural modeling predicted displacement of the mutant lysine side chain from a DNA phosphate group, loss of a hydrogen bond, and impaired DNA-binding activity. (alasti2009geneticsofmicrotia pages 11-14)
A commonly reported transcript-level rendering is c.557A>C (p.Gln186Lys), but clinical laboratories should normalize HGVS against the current MANE transcript rather than copying historical nomenclature uncritically. The original interpretation predates ACMG/AMP standards. The combination of strong linkage, recessive segregation, absence from controls, conservation, phenotype concordance, and model support is compelling, but the retrieved evidence did not show a patient-cell transcription assay. Thus, pathogenic/likely pathogenic reassessment in a current clinical laboratory is preferable to treating the historical label as an automatically current ClinVar classification.
General microtia studies discuss maternal/perinatal and environmental associations, but those data must not be assigned to this single-gene syndrome. General microtia prevalence and associated-anomaly figures likewise do not estimate this syndrome’s incidence. (llanos2023riskfactorsfor pages 5-7, wahdini2024genotypephenotypeassociationsin pages 14-16)
No protective allele, diet, exposure, medication, or lifestyle intervention is known. No syndrome-specific gene–environment interaction has been demonstrated. Standard avoidance of recognized teratogens is sound prenatal practice but is not proven to prevent HOXA2-associated disease.
All principal findings are congenital, although hearing impairment may be documented only after newborn screening or diagnostic audiology.
| Phenotype | Type and characteristics | Frequency evidence | Suggested HPO term |
|---|---|---|---|
| Bilateral Marx type II microtia | Physical sign; congenital, stable structural malformation; severity substantial but short of anotia | Core finding in the four reported relatives; not a population frequency | Bilateral microtia, HP:0008551; Microtia, HP:0008551—verify the current bilateral child term/version |
| Mixed hearing impairment | Functional sign; prelingual, symmetric, severe-to-profound; likely lifelong without habilitation | Core family phenotype | Mixed hearing impairment, HP:0000410; Severe hearing impairment, HP:0012715; Profound hearing impairment, HP:0012714; Congenital hearing impairment, HP:0008527 |
| Partial/incomplete cleft palate | Congenital physical sign; stable anatomical defect until repaired | Core family phenotype | Cleft palate, HP:0000175; Incomplete cleft palate—use current HPO child term if available |
| Unilateral cochlear aplasia | Imaging/anatomical abnormality; congenital, nonprogressive | One of four reported patients, but 1/4 is not a generalizable frequency | Absent cochlea, HP:0011372; Unilateral abnormality qualifier where supported |
| External/middle-ear malformation | Structural correlate inferred from microtia and mixed conductive component; directly emphasized in the clinical review | Predominant affected auditory compartments; exact person-level frequency unavailable | Abnormal external ear morphology, HP:0000356; Abnormal middle ear morphology, HP:0000370 |
The literature does not establish developmental delay, intellectual disability, seizures, renal disease, cardiac disease, immunodeficiency, or metabolic abnormalities as features of this syndrome. These should not be added based merely on broader syndromic-microtia differentials.
No syndrome-specific EQ-5D, SF-36, PROMIS, speech, educational, or psychosocial data exist. Expected burdens include impaired access to spoken language from bilateral severe/profound prelingual hearing loss, feeding and speech difficulties from cleft palate, repeated procedures, and appearance-related psychosocial stress. These are extrapolations. A 2023 narrative review of 64 microtia/craniofacial-microsomia studies found care stressful from diagnosis, possible social and language risks, and generally high satisfaction after reconstruction/canaloplasty; it did not study this HOXA2 syndrome specifically.
HOXA2 encodes a nuclear homeobox transcription factor that binds DNA through its homeodomain and specifies positional identity during craniofacial development. The disease allele is germline, not somatic. No recurrent founder allele, carrier frequency, gnomAD frequency, or additional unrelated recessive family with the full triad was established in the retrieved evidence.
The p.Gln186Lys substitution affects a highly conserved residue in the DNA-binding homeodomain. Its modeled effect—loss of a DNA-contact hydrogen bond—supports reduced transcription-factor function. Complete biochemical loss of function, gain of function, or dominant-negative activity was not directly demonstrated in patient cells; the recessive inheritance and mouse loss-of-function concordance favor a hypomorphic/loss-of-function mechanism. (alasti2009geneticsofmicrotia pages 11-14)
Other heterozygous nonsense/frameshift HOXA2 alleles cause dominant microtia with variable hearing impairment, demonstrating dosage sensitivity but a distinguishable phenotype and inheritance pattern. Reported dominant alleles include truncating variants around Glu224, Glu229, and Gln235; these are useful differential evidence, not variants causing the defining recessive syndrome. (meddaugh2020novelhoxa2variant pages 3-3)
No syndrome-specific:
has been reported.
A 2024 study identified an approximately 600-kb noncoding global control region between NPVF and NFE2L3 that interacts over long distances with anterior HOXA genes in human and mouse embryonic craniofacial tissue. Mouse deletion caused perinatal lethality, skull defects, and highly penetrant orofacial clefts resembling Hoxa2-null phenotypes; two humans with de novo copy-number changes had severe craniofacial abnormalities. This is important evidence for HOXA regulatory architecture, but it is not evidence that those CNVs cause MONDO:0012854, nor does it reclassify p.Gln186Lys. (wilderman2024adistantglobal pages 13-13, wilderman2024adistantglobal pages 1-2)
No toxin, radiation exposure, pollution source, infection, diet, smoking, alcohol exposure, or other lifestyle factor has been shown to cause or modify this HOXA2 syndrome. It is noninfectious and nontransmissible. Environmental associations reported for microtia overall concern etiologically heterogeneous cases and cannot be causally imported into this Mendelian entry.
HOXA2 is better understood as a developmental transcriptional identity regulator than as a component of one canonical kinase cascade. Its critical context is the HOX regulatory network in cranial neural crest and pharyngeal-arch mesenchyme. Proposed downstream auricular effectors include BMP4, BMP5, and TWSG1, linking HOXA2 to BMP-dependent cartilage proliferation and differentiation, but their exact contribution to the human syndrome is unproven. (sparascio2017studyofmolecular pages 16-20)
Relevant suggested ontology annotations include:
There is no evidence for primary inflammation, autoimmunity, immunodeficiency, fibrosis, ischemia, enzyme deficiency, channelopathy, or systemic metabolic disturbance. No syndrome-specific patient transcriptome, proteome, metabolome, lipidome, single-cell atlas, spatial transcriptome, CRISPR screen, organoid, or multi-omics profile was identified. Broader 2024 microtia cartilage studies reporting noncoding-RNA and extracellular-matrix signatures used nonsyndromic tissue and should not be annotated as HOXA2-syndrome molecular profiles.
Primary sites are the bilateral auricles/pinnae, external and middle auditory apparatus, palate, and potentially inner ear/cochlea. The external and middle ear derive substantially from first- and second-pharyngeal-arch structures, whereas the inner ear has otic-placode origins. HOXA2 is especially important in second-arch cranial-neural-crest mesenchyme; mixed arch origins help explain why some auricular substructures, such as the tragus, may be relatively spared. (cox2014thegeneticsof pages 3-4, alasti2009geneticsofmicrotia pages 5-8)
Suggested anatomical mappings:
Subcellular dysfunction is centered on the nucleus and DNA-bound transcriptional regulatory complexes. Lateralization is bilateral for microtia and reported hearing impairment; cochlear aplasia was unilateral in one individual.
The initiating defect acts during embryonic craniofacial organogenesis, particularly pharyngeal-arch, auricular, ossicular, otic, and palatal development. The anatomical malformations are congenital and structurally stable rather than inflammatory, episodic, or relapsing.
Hearing impairment is congenital/prelingual and expected to be lifelong, although its functional impact can improve markedly with early amplification, surgery when anatomically suitable, and communication intervention. Cleft palate persists until repaired; residual velopharyngeal, speech, dental, or otologic problems can continue afterward. No syndrome-specific stages, progression rate, remission pattern, or adult natural history have been documented.
Critical clinical windows are early infancy for objective hearing diagnosis and amplification, infancy for feeding and palate planning, early childhood for speech/language intervention, and later childhood for anatomy-dependent auditory and auricular reconstruction. These windows derive from general care standards, not a HOXA2-specific trial. (truong2022integratedmicrotiaand pages 4-6, truong2022integratedmicrotiaand pages 2-4)
Inheritance in the defining pedigree is autosomal recessive. For two heterozygous carrier parents, standard Mendelian counseling gives each pregnancy a 25% probability of an affected child, 50% probability of an unaffected carrier, and 25% probability of inheriting neither familial allele, assuming full genotype penetrance. Actual penetrance of p.Gln186Lys cannot be estimated independently from one pedigree.
Only four affected individuals from one consanguineous Iranian family were reported in the available HOX-disorder literature. There are no defensible syndrome-specific estimates of prevalence, incidence, sex ratio, carrier frequency, geographic distribution, age distribution, founder effect, germline-mosaicism rate, or reproductive fitness. (alasti2009geneticsofmicrotia pages 11-14, alasti2009geneticsofmicrotia pages 18-20)
General microtia estimates—such as 0.8–17.5 per 10,000 births, male predominance, or mainly unilateral disease—describe heterogeneous microtia and must not populate this syndrome’s epidemiology fields. A 2024 systematic review included 1,459 microtia patients across 40 phenotype papers but did not establish syndrome-specific population statistics for the recessive HOXA2 triad. (wahdini2024genotypephenotypeassociationsin pages 14-16)
Anticipation is not expected for a missense allele and has not been observed. Variable expressivity is suggested by cochlear aplasia in only one relative, but precise penetrance and expressivity remain unknown.
Diagnosis begins with congenital bilateral microtia plus objective bilateral hearing loss and cleft-palate examination. Infants with microtia/atresia should be referred directly to pediatric audiology regardless of newborn-screening outcome. Diagnostic auditory brainstem response should ideally be completed by two months and no later than three months, including air- and bone-conduction thresholds and masked bone conduction where feasible. Tympanometry and otoacoustic emissions should be performed where anatomy permits, followed by behavioral audiometry from approximately six months and regular monitoring through early childhood. These recommendations are extrapolated from expert microtia/atresia guidance. (truong2022integratedmicrotiaand pages 4-6, truong2022integratedmicrotiaand pages 2-4)
Temporal-bone high-resolution noncontrast CT defines canal, ossicular, middle-ear, and cochlear anatomy and is useful for reconstructive candidacy. Routine CT is often deferred until approximately age five or until operative planning, limiting radiation exposure; earlier imaging may be justified for sensorineural loss, suspected cholesteatoma/fistula, or major inner-ear disease. Diffusion-weighted MRI is useful when cholesteatoma is suspected, and MRI is important for cochlear nerve and membranous-labyrinth assessment when cochlear implantation is considered. (truong2022integratedmicrotiaand pages 4-6, paul2021congenitalabnormalitiesassociated pages 3-3)
Cleft evaluation should include feeding, airway, otologic, speech-language, dental/orthodontic, and velopharyngeal assessment. No blood chemistry, urine test, enzyme assay, biopsy, metabolite, or circulating biomarker diagnoses the syndrome.
Familial variants require Sanger or equivalent orthogonal confirmation and segregation analysis. RNA sequencing is not an established diagnostic test for p.Gln186Lys, although it may help investigate splice or regulatory variants in unresolved cases.
Important alternatives include:
There are no standardized syndrome-specific clinical diagnostic criteria; molecular confirmation is therefore important.
This syndrome is not part of routine biochemical newborn screening. Applicable measures are universal newborn hearing screening, immediate diagnostic follow-up, and cascade testing for the familial HOXA2 variant. Carrier, prenatal, and preimplantation testing are technically possible once the familial pathogenic variant is established.
No survival curves, mortality rates, life-expectancy estimates, hospitalization rates, or validated prognostic biomarkers exist. The four reported human patients survived beyond the neonatal period, unlike Hoxa2-null mice; therefore, mouse neonatal lethality should not be assigned to affected humans. (alasti2009geneticsofmicrotia pages 11-14)
Likely long-term morbidity is auditory-communication disability, reconstructive burden, and cleft-associated feeding, speech, dental, and psychosocial effects. Prognosis depends more on anatomy and access/timing of habilitation than on a demonstrated progressive molecular process. Particularly relevant prognostic features include residual cochlear and cochlear-nerve anatomy, bone-conduction thresholds, middle-ear anatomy, device use, age at intervention, palate repair result, and access to speech/language and educational services. No molecular marker predicts severity.
There is no therapy that reverses the embryonic HOXA2 lesion. Care is individualized and multidisciplinary, involving clinical genetics, pediatric otolaryngology, audiology, cleft/craniofacial surgery, plastic surgery, speech-language pathology, dentistry/orthodontics, pediatrics, psychology, and educational services. Close coordination is essential because canal/hearing surgery can affect later auricular reconstruction. (zhang2019internationalconsensusrecommendations pages 2-3, truong2022integratedmicrotiaand pages 1-2)
For bilateral disease, expert guidance recommends diagnostic assessment by 2–3 months, amplification by about 4 months, and early intervention by 3–6 months. Nonimplantable bone-conduction systems—softband BAHA/Ponto-type processors or adhesive systems—are common early options where cochlear function is adequate. Because the syndrome causes mixed, not necessarily purely conductive, loss and can include cochlear aplasia, treatment must be based on ear-specific air/bone thresholds and imaging. Cochlear implantation may be considered only when sensorineural loss is severe/profound and a stimulable cochlea/cochlear nerve is present; unilateral cochlear absence can make that side unsuitable. (truong2022integratedmicrotiaand pages 4-6, silva2023taskforceguideline pages 2-3)
Atresiaplasty or middle-ear reconstruction requires adequate inner-ear function and favorable anatomy. International consensus supports the Jahrsdoerfer CT scale and generally considers a score of at least 7 favorable. Implantable bone-conduction or middle-ear devices are typically considered after approximately age five, depending on device approval, skull thickness, anatomy, and local practice. (zhang2019internationalconsensusrecommendations pages 2-3)
Suggested NCIt concepts include Hearing Aid Device, Bone Conduction Hearing Device, Cochlear Implantation, Auditory Rehabilitation, and Speech Therapy; exact NCIt codes should be version-checked.
Primary palatoplasty is generally performed during infancy within an accredited cleft pathway, followed by surveillance for fistula, velopharyngeal dysfunction, otitis media, hearing deterioration, dentofacial growth, and articulation. Speech-language therapy is often required. Exact timing and technique should follow the treating cleft team’s protocol; no HOXA2-specific comparison exists.
Options include autologous costal cartilage reconstruction, porous polyethylene framework, or an adhesive/osseointegrated prosthesis. Consensus sources place autologous cartilage reconstruction approximately from 5–9 years onward, often around nine years when rib cartilage is adequate; porous polyethylene may be considered after about five years. Canal surgery should be sequenced with the reconstruction method—generally before polyethylene reconstruction but after or combined with rib-cartilage reconstruction. (zhang2019internationalconsensusrecommendations pages 2-3, truong2022integratedmicrotiaand pages 16-17)
No disease-specific drug, pharmacogenomic recommendation, gene therapy, genome editing, RNA therapy, cell therapy, immunotherapy, or targeted molecular therapy exists. Medicines are used only for routine perioperative care, otitis, pain, or other complications.
No interventional trial specifically for MONDO:0012854 or HOXA2 p.Gln186Lys was identified. Trials of hearing devices or ear reconstruction in heterogeneous microtia/ear-aplasia populations are not disease-modifying and cannot supply syndrome-specific response rates.
Because the disorder is inherited, lifestyle modification, vaccination, sanitation, and prophylactic medication cannot prevent expression in a fetus who inherits the causal biallelic genotype.
For carrier parents, recurrence counseling is 25% per pregnancy under standard autosomal-recessive assumptions. Testing should be accompanied by counseling about uncertain phenotype prediction, especially the risk of inner-ear involvement.
No naturally occurring animal disease proven to reproduce the complete human bilateral microtia–deafness–cleft-palate syndrome from the orthologous p.Gln186Lys allele was identified. There is no zoonotic or cross-species transmission.
The most relevant ortholog is mouse Hoxa2 in Mus musculus (NCBI Taxonomy 10090). HOXA2 function is evolutionarily conserved in vertebrate craniofacial patterning. Other animal microtia caused by distinct genes or enhancer duplications may inform auricular morphogenesis but should not be represented as natural HOXA2 syndrome.
Hoxa2-null mice lack the external pinna, exhibit transformations/duplications of middle-ear bones, and develop a wide secondary-palate cleft. They die within about 24 hours, probably because the cleft prevents effective feeding. These models strongly recapitulate the affected anatomical systems but are more severe than the surviving human missense phenotype. (alasti2009geneticsofmicrotia pages 11-14)
Lineage and ectopic-expression experiments establish that Hoxa2 specifies second-pharyngeal-arch identity in cranial-neural-crest-derived mesenchyme. Loss produces homeotic transformation and duplicated first-arch-like skeletal elements; ectopic first-arch expression can produce mirror-image auricular duplication. These models are useful for dissecting pinna, auditory-meatus, ossicle, and palate morphogenesis. (cox2014thegeneticsof pages 3-3, alasti2009geneticsofmicrotia pages 5-8)
Dosage experiments also show that cranial neural crest is highly sensitive to Hoxa2 level: ectopic expression at approximately 60% of normal second-arch levels was sufficient for pinna duplication, while higher levels produced progressively broader homeotic or destructive craniofacial phenotypes. This supports dosage sensitivity but does not quantify residual activity of human p.Gln186Lys.
The 2024 global-control-region deletion mouse provides a regulatory model for anterior HOXA insufficiency and orofacial clefting, not a precise knock-in model of the human missense allele. (wilderman2024adistantglobal pages 1-2)
No syndrome-specific p.Gln186Lys knock-in mouse, zebrafish model, patient-derived fibroblast/iPSC line, cranial-neural-crest culture, ear organoid, palate organoid, or CRISPR rescue study was identified. A priority model would be an isogenic human iPSC pair differentiated into cranial neural crest and chondro-osteogenic derivatives, coupled to HOXA2 occupancy and target-gene assays. Such work could distinguish partial loss of DNA binding from altered target specificity and test why the human phenotype is viable whereas complete mouse loss is lethal.
The most important 2023–2024 development is not a new treatment but recognition that anterior HOXA expression depends on distant, tissue-specific regulatory architecture. Human embryonic craniofacial epigenomics and mouse deletion experiments now show that noncoding structural variants far from HOXA2 can perturb the same developmental program. Meanwhile, a 2024 systematic review confirmed substantial genetic heterogeneity across microtia and concluded that more complete genotype–phenotype datasets are needed. These findings support using WGS and CNV analysis in unresolved cases, but they do not expand the proven case count for the defining recessive syndrome. (wilderman2024adistantglobal pages 13-13, wilderman2024adistantglobal pages 1-2, wahdini2024genotypephenotypeassociationsin pages 14-16)
The highest-priority knowledge gaps are: identification of unrelated biallelic HOXA2 cases; contemporary ACMG/AMP curation and population-frequency analysis of p.Gln186Lys; standardized deep phenotyping of auditory canals, ossicles, cochleae and palate; long-term hearing, speech, educational and psychosocial outcomes; and patient-derived functional models. Until such data exist, the disease knowledge-base entry should prominently state “ultra-rare; evidence based on one family; frequencies and prognosis unknown.”
References
(alasti2009geneticsofmicrotia pages 11-14): F Alasti and G Van Camp. Genetics of microtia and associated syndromes. Mar 2009. URL: https://doi.org/10.1136/jmg.2008.062158, doi:10.1136/jmg.2008.062158. This article has 222 citations and is from a domain leading peer-reviewed journal.
(alasti2009geneticsofmicrotia pages 18-20): F Alasti and G Van Camp. Genetics of microtia and associated syndromes. Mar 2009. URL: https://doi.org/10.1136/jmg.2008.062158, doi:10.1136/jmg.2008.062158. This article has 222 citations and is from a domain leading peer-reviewed journal.
(OpenTargets Search: Bilateral microtia-deafness-cleft palate syndrome-HOXA2): Open Targets Query (Bilateral microtia-deafness-cleft palate syndrome-HOXA2, 1 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(cox2014thegeneticsof pages 3-3): Timothy C. Cox, Esra D. Camci, Siddharth Vora, Daniela V. Luquetti, and Eric E. Turner. The genetics of auricular development and malformation: new findings in model systems driving future directions for microtia research. European journal of medical genetics, 57 8:394-401, Aug 2014. URL: https://doi.org/10.1016/j.ejmg.2014.05.003, doi:10.1016/j.ejmg.2014.05.003. This article has 125 citations and is from a peer-reviewed journal.
(alasti2009geneticsofmicrotia pages 5-8): F Alasti and G Van Camp. Genetics of microtia and associated syndromes. Mar 2009. URL: https://doi.org/10.1136/jmg.2008.062158, doi:10.1136/jmg.2008.062158. This article has 222 citations and is from a domain leading peer-reviewed journal.
(cox2014thegeneticsof pages 3-4): Timothy C. Cox, Esra D. Camci, Siddharth Vora, Daniela V. Luquetti, and Eric E. Turner. The genetics of auricular development and malformation: new findings in model systems driving future directions for microtia research. European journal of medical genetics, 57 8:394-401, Aug 2014. URL: https://doi.org/10.1016/j.ejmg.2014.05.003, doi:10.1016/j.ejmg.2014.05.003. This article has 125 citations and is from a peer-reviewed journal.
(truong2022integratedmicrotiaand pages 4-6): Mai Thy Truong, Yi-Chun Carol Liu, Jocelyn Kohn, Sivakumar Chinnadurai, David A. Zopf, Melissa Tribble, Paul B. Tanner, Kathleen Sie, and Kay W. Chang. Integrated microtia and aural atresia management. Frontiers in Surgery, Dec 2022. URL: https://doi.org/10.3389/fsurg.2022.944223, doi:10.3389/fsurg.2022.944223. This article has 39 citations.
(truong2022integratedmicrotiaand pages 2-4): Mai Thy Truong, Yi-Chun Carol Liu, Jocelyn Kohn, Sivakumar Chinnadurai, David A. Zopf, Melissa Tribble, Paul B. Tanner, Kathleen Sie, and Kay W. Chang. Integrated microtia and aural atresia management. Frontiers in Surgery, Dec 2022. URL: https://doi.org/10.3389/fsurg.2022.944223, doi:10.3389/fsurg.2022.944223. This article has 39 citations.
(paul2021congenitalabnormalitiesassociated pages 3-3): Antoine Paul, Sophie Achard, François Simon, Nicolas Garcelon, Erea Noel Garabedian, Vincent Couloigner, Charlotte Celerier, and Françoise Denoyelle. Congenital abnormalities associated with microtia: a 10-years retrospective study. Jul 2021. URL: https://doi.org/10.1016/j.ijporl.2021.110764, doi:10.1016/j.ijporl.2021.110764. This article has 24 citations and is from a peer-reviewed journal.
(zhang2019internationalconsensusrecommendations pages 2-3): Tian-yu Zhang, Neil Bulstrode, Kay W. Chang, Yang-Sun Cho, Henning Frenzel, Dan Jiang, Bradley W. Kesser, Ralf Siegert, and Jean-Michel Triglia. International consensus recommendations on microtia, aural atresia and functional ear reconstruction. Aug 2019. URL: https://doi.org/10.5152/iao.2019.7383, doi:10.5152/iao.2019.7383. This article has 175 citations and is from a peer-reviewed journal.
(truong2022integratedmicrotiaand pages 16-17): Mai Thy Truong, Yi-Chun Carol Liu, Jocelyn Kohn, Sivakumar Chinnadurai, David A. Zopf, Melissa Tribble, Paul B. Tanner, Kathleen Sie, and Kay W. Chang. Integrated microtia and aural atresia management. Frontiers in Surgery, Dec 2022. URL: https://doi.org/10.3389/fsurg.2022.944223, doi:10.3389/fsurg.2022.944223. This article has 39 citations.
(truong2022integratedmicrotiaand pages 1-2): Mai Thy Truong, Yi-Chun Carol Liu, Jocelyn Kohn, Sivakumar Chinnadurai, David A. Zopf, Melissa Tribble, Paul B. Tanner, Kathleen Sie, and Kay W. Chang. Integrated microtia and aural atresia management. Frontiers in Surgery, Dec 2022. URL: https://doi.org/10.3389/fsurg.2022.944223, doi:10.3389/fsurg.2022.944223. This article has 39 citations.
(wilderman2024adistantglobal pages 13-13): Andrea Wilderman, Eva D’haene, Machteld Baetens, Tara N. Yankee, Emma Wentworth Winchester, Nicole Glidden, Ellen Roets, Jo Van Dorpe, Sandra Janssens, Danny E. Miller, Miranda Galey, Kari M. Brown, Rolf W. Stottmann, Sarah Vergult, K. Nicole Weaver, Samantha A. Brugmann, Timothy C. Cox, and Justin Cotney. A distant global control region is essential for normal expression of anterior hoxa genes during mouse and human craniofacial development. Nature Communications, Jan 2024. URL: https://doi.org/10.1038/s41467-023-44506-2, doi:10.1038/s41467-023-44506-2. This article has 20 citations and is from a highest quality peer-reviewed journal.
(wilderman2024adistantglobal pages 1-2): Andrea Wilderman, Eva D’haene, Machteld Baetens, Tara N. Yankee, Emma Wentworth Winchester, Nicole Glidden, Ellen Roets, Jo Van Dorpe, Sandra Janssens, Danny E. Miller, Miranda Galey, Kari M. Brown, Rolf W. Stottmann, Sarah Vergult, K. Nicole Weaver, Samantha A. Brugmann, Timothy C. Cox, and Justin Cotney. A distant global control region is essential for normal expression of anterior hoxa genes during mouse and human craniofacial development. Nature Communications, Jan 2024. URL: https://doi.org/10.1038/s41467-023-44506-2, doi:10.1038/s41467-023-44506-2. This article has 20 citations and is from a highest quality peer-reviewed journal.
(alasti2008amutationin pages 1-1): Fatemeh Alasti, Abdorrahim Sadeghi, Mohammad Hossein Sanati, Mohammad Farhadi, Elliot Stollar, Thomas Somers, and Guy Van Camp. A mutation in hoxa2 is responsible for autosomal-recessive microtia in an iranian family. Sep 2008. URL: https://doi.org/10.1016/j.ajhg.2008.08.014, doi:10.1016/j.ajhg.2008.08.014. This article has 141 citations.
(meddaugh2020novelhoxa2variant pages 3-3): Hannah R. Meddaugh and Regina M. Zambrano. Novel hoxa2 variant presenting with microtia and variable hearing impairment in four-generation pedigree. Clinical Dysmorphology, 29:104-106, Apr 2020. URL: https://doi.org/10.1097/mcd.0000000000000297, doi:10.1097/mcd.0000000000000297. This article has 6 citations and is from a peer-reviewed journal.
(sparascio2017studyofmolecular pages 16-20): F Piceci Sparascio. Study of molecular basis of oculo-auricolo-vertebral-spectrum. Unknown journal, 2017.
(llanos2023riskfactorsfor pages 5-7): Sheyla Teresa Navas Llanos and Carmen Barba Guzmán Variña. Risk factors for microtia and preventive approaches. Sapienza: International Journal of Interdisciplinary Studies, 4:e23046, Sep 2023. URL: https://doi.org/10.51798/sijis.v4isi1.707, doi:10.51798/sijis.v4isi1.707. This article has 2 citations.
(wahdini2024genotypephenotypeassociationsin pages 14-16): Siti Isya Wahdini, Fina Idamatussilmi, Rachmaniar Pramanasari, Almas Nur Prawoto, Citrawati Dyah Kencono Wungu, Indri Lakhsmi Putri, and Gunadi. Genotype-phenotype associations in microtia: a systematic review. Orphanet Journal of Rare Diseases, Apr 2024. URL: https://doi.org/10.1186/s13023-024-03142-9, doi:10.1186/s13023-024-03142-9. This article has 17 citations and is from a peer-reviewed journal.
(silva2023taskforceguideline pages 2-3): VAR Silva, HF Pauna, and J Lavinsky. Task force guideline of brazilian society of otology–hearing loss in children–part ii–treatment. Unknown journal, 2023.
Checked with linkml-reference-validator 0.2.1.
| Outcome | Count |
|---|---|
| References checked | 11 |
| Resolved | 11 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 0 |
| References weighed for topical relevance | 11 |
| On topic | 2 |
| Off topic | 1 |
These identifiers resolve, so they are not fabrications, but the records they resolve to share almost none of this report's vocabulary. That is a clue and not a verdict - a paper can be relevant in ways its title and abstract do not spell out - so read them before deciding:
DOI:10.5152/iao.2019.7383 (3 mentions) - International Consensus Recommendations on Microtia, Aural Atresia and Functional Ear ReconstructionWeighed against this report's own most characteristic terms: disease, microtia, hoxa2, palate, syndrome, clinical, hearing, human, gene, genetic, bilateral, cleft, phenotype, loss, model, variant, affected, syndrome-specific, molecular, diagnostic.
All extracted references resolved successfully. Resolving is not the same as being relevant, though - see the references listed above as possibly off topic.
Checked with linkml-term-validator 0.4.5, through the ols: adapter.
| Outcome | Count |
|---|---|
| Terms checked | 29 |
| Resolved | 29 |
| Unresolved (possible confabulation) | 0 |
| Obsolete | 0 |
| Unverifiable | 0 |
| Terms whose name was checked | 2 |
| Terms named correctly | 0 |
| Terms named as a different term | 0 |
| Terms whose name is worth a second look | 2 |
The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:
GO:0009952 (1 mention) - the report calls it "GO biological process: anterior/posterior pattern specification"; GO calls it anterior/posterior pattern specification**GO:0005634 (1 mention) - the report calls it "GO cellular component: nucleus"; GO calls it nucleus**, and lists "cell nucleus" among its other namesEvery term resolved, and every label the report gave matched.